Edgar Filing: Colfax CORP

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 28, 2012

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number - 001-34045

Colfax Corporation

(Exact name of registrant as specified in its charter)

Delaware		54-1887631
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

8170 Maple Lawn Boulevard, Suite 180 Fulton, Maryland		20759
(Address of principal executive offices)		(Zip Code)

(301) 323-9000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨ Accelerated filer þ

Non-accelerated filer ¨	(Do not check if a smaller reporting company)	Smaller reporting company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ

As of September 28, 2012, there were 93,977,842 shares of the registrant’s common stock, par value $.001 per share, outstanding.

TABLE OF CONTENTS

	Page
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements	3
Condensed Consolidated Statements of Operations	3
Condensed Consolidated Statements of Comprehensive Income (Loss)	4
Condensed Consolidated Balance Sheets	5
Condensed Consolidated Statement of Equity	6
Condensed Consolidated Statements of Cash Flows	7
Notes to Condensed Consolidated Financial Statements	8
Note 1. General	8
Note 2. Accounting Policies	9
Note 3. Recently Issued Accounting Pronouncements	10
Note 4. Acquisitions	10
Note 5. Goodwill and Intangible Assets	13
Note 6. Net Income (Loss) Per Share	14
Note 7. Income Taxes	14
Note 8. Property, Plant and Equipment, Net	16
Note 9. Inventories, Net	17
Note 10. Debt	17
Note 11. Equity	19
Note 12. Accrued Liabilities	22
Note 13. Net Periodic Benefit Cost – Defined Benefit Plans	24
Note 14. Financial Instruments and Fair Value Measurements	24
Note 15. Commitments and Contingencies	27
Note 16. Segment Information	29
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	32
Item 3. Quantitative and Qualitative Disclosures About Market Risk	44
Item 4. Controls and Procedures	46

PART II – OTHER INFORMATION	46
Item 1. Legal Proceedings	46
Item 1A. Risk Factors	46
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	46
Item 3. Defaults Upon Senior Securities	46
Item 4. Mine Safety Disclosures	47
Item 5. Other Information	47
Item 6. Exhibits	48

SIGNATURES	49

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

COLFAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Dollars in thousands, except per share amounts

(Unaudited)

	Three Months Ended				Nine Months Ended
	September 28, 2012		September 30, 2011		September 28, 2012			September 30, 2011
Net sales	$	954,440	$	170,294	$	2,886,459		$	515,601
Cost of sales		666,453		109,667		2,041,904			337,046
Gross profit		287,987		60,627		844,555			178,555
Selling, general and administrative expense		217,143		41,074		661,191			123,376
Charter acquisition-related expense		—		5,728		43,617			5,728
Restructuring and other related charges		15,865		5,299		43,066			7,518
Asbestos coverage litigation expense		3,313		3,086		8,840			8,454
Operating income		51,666		5,440		87,841			33,479
Interest expense		23,557		1,218		68,280			4,507
Income before income taxes		28,109		4,222		19,561			28,972
Provision for income taxes		13,610		532		86,891			8,337
Net income (loss)		14,499		3,690		(67,330	)		20,635
Less: income attributable to noncontrolling interest, net of taxes		5,405		—		16,808			—
Net income (loss) attributable to Colfax Corporation		9,094		3,690		(84,138	)		20,635
Dividends on preferred stock		5,072		—		13,879			—
Net income (loss) available to Colfax Corporation common shareholders	$	4,022	$	3,690	$	(98,017	)	$	20,635
Net income (loss) per share—basic and diluted	$	0.04	$	0.08	$	(1.09	)	$	0.47

See Notes to Condensed Consolidated Financial Statements.

COLFAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

Dollars in thousands

(Unaudited)

	Three Months Ended						Nine Months Ended
	September 28, 2012			September 30, 2011			September 28, 2012			September 30, 2011
Net income (loss) attributable to Colfax Corporation	$	9,094		$	3,690		$	(84,138	)	$	20,635
Other comprehensive income (loss):
Foreign currency translation, net of tax of $(555), $53, $(495) and $210		59,474			(15,216	)		81,804			(2,470	)
Unrealized gain (loss) on hedging activities, net of tax of $538, $0, $346 and $0		1,211			(13	)		(748	)		(146	)
Amounts reclassified to net income (loss):
Realized loss on hedging activities, net of tax of $0, $0, $0 and $0		—			251			471			1,231
Pension and other postretirement benefit cost, net of tax of $53, $1,234, $162 and $2,117		2,074			1,161			6,232			3,762
Other comprehensive income (loss)		62,759			(13,817	)		87,759			2,377
Less: other comprehensive loss attributable to noncontrolling interest, net of tax of $0, $0, $0 and $0		(3,207	)		—			(4,537	)		—
Other comprehensive income (loss) attributable to Colfax Corporation		65,966			(10,127	)		92,296			2,377
Comprehensive income (loss) attributable to Colfax Corporation common shareholders	$	75,060		$	(10,127	)	$	8,158		$	23,012

See Notes to Condensed Consolidated Financial Statements.

COLFAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

Dollars in thousands, except share amounts

(Unaudited)

	September 28, 2012			December 31, 2011
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	517,343		$	75,108
Trade receivables, less allowance for doubtful accounts of $8,920 and $2,578		882,867			117,475
Inventories, net		519,358			56,136
Other current assets		313,948			102,489
Total current assets		2,233,516			351,208
Property, plant and equipment, net		662,294			90,939
Goodwill		1,929,436			204,844
Intangible assets, net		745,583			41,029
Other assets		484,895			400,523
Total assets	$	6,055,724		$	1,088,543

LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Current portion of long-term debt	$	34,033		$	10,000
Accounts payable		636,521			54,035
Accrued liabilities		550,060			176,007
Total current liabilities		1,220,614			240,042
Long-term debt, less current portion		1,659,070			101,518
Other liabilities		996,343			557,708
Total liabilities		3,876,027			899,268
Equity:
Preferred stock, $0.001 par value; 20,000,000 and 10,000,000 shares authorized; 13,877,552 and none issued and outstanding		14			—
Common stock, $0.001 par value; 400,000,000 and 200,000,000 shares authorized; 93,977,842 and 43,697,570 issued and outstanding		94			44
Additional paid-in capital		2,191,064			415,527
Accumulated deficit		(153,520	)		(55,503	)
Accumulated other comprehensive loss		(81,141	)		(170,793	)
Total Colfax Corporation equity		1,956,511			189,275
Noncontrolling interest		223,186			—
Total equity		2,179,697			189,275
Total liabilities and equity	$	6,055,724		$	1,088,543

See Notes to Condensed Consolidated Financial Statements.

COLFAX CORPORATION

CONDENSED CONSOLIDATED STATEMENT OF EQUITY

Dollars in thousands, except share amounts and as noted

(Unaudited)

	Common Stock				Preferred Stock				Additional Paid-In			Accumulated			Accumulated Other Comprehensive			Noncontrolling
	Shares		$ Amount		Shares		$ Amount		Capital			Deficit			Loss			Interest			Total
Balance at January 1, 2012		43,697,570	$	44		—	$	—	$	415,527		$	(55,503	)	$	(170,793	)	$	—		$	189,275
Net (loss) income		—		—		—		—		—			(84,138	)		—			16,808			(67,330	)
Charter Acquisition		—		—		—		—		—			—			—			236,257			236,257
ESAB India repurchase of additional noncontrolling interest		—		—		—		—		(1,305	)		—			(2,644	)		(25,342	)		(29,291	)
Preferred stock dividend		—		—		—		—		—			(13,879	)		—			—			(13,879	)
Other comprehensive income (loss)		—		—		—		—		—			—			92,296			(4,537	)		87,759
Common stock issuances, net of costs of $20.2 million		49,917,786		50		—		—		1,432,921			—			—			—			1,432,971
Preferred stock issuance, net of costs of $7.0 million		—		—		13,877,552		14		332,958			—			—			—			332,972
Common stock-based award activity		362,486		—		—		—		10,963			—			—			—			10,963
Balance at September 28, 2012		93,977,842	$	94		13,877,552	$	14	$	2,191,064		$	(153,520	)	$	(81,141	)	$	223,186		$	2,179,697

See Notes to Condensed Consolidated Financial Statements.

COLFAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Dollars in thousands

(Unaudited)

	Nine Months Ended
	September 28, 2012			September 30, 2011

Cash flows from operating activities:
Net (loss) income	$	(67,330	)	$	20,635
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation, amortization and fixed asset impairment charges		151,278			18,166
Stock-based compensation expense		6,429			3,885
Deferred income tax provision		40,176			2,193
Changes in operating assets and liabilities, net of acquisitions:
Trade receivables, net		(70,304	)		1,800
Inventories, net		(27,627	)		(11,229	)
Changes in other operating assets and liabilities		(31,500	)		6,228
Net cash provided by operating activities		1,122			41,678

Cash flows from investing activities:
Purchases of fixed assets, net		(58,635	)		(10,717	)
Acquisitions, net of cash received		(1,691,982	)		(22,299	)
Net cash used in investing activities		(1,750,617	)		(33,016	)

Cash flows from financing activities:
Borrowings under term credit facility		1,731,523			—
Payments under term credit facility		(521,099	)		(7,500	)
Proceeds from borrowings on revolving credit facilities		13,149			78,646
Repayments of borrowings on revolving credit facilities		(52,637	)		(78,646	)
Payments of deferred loan costs		(9,795	)		—
Proceeds from issuance of common stock, net		755,113			2,195
Proceeds from issuance of preferred stock, net		332,969			—
ESAB India repurchase of additional noncontrolling interest		(29,291	)		—
Payment of dividend on preferred stock		(12,374	)		—
Net cash provided by (used in) financing activities		2,207,558			(5,305	)
Effect of foreign exchange rates on cash and cash equivalents		(15,828	)		548
Increase in cash and cash equivalents		442,235			3,905
Cash and cash equivalents, beginning of period		75,108			60,542
Cash and cash equivalents, end of period	$	517,343		$	64,447

See Notes to Condensed Consolidated Financial Statements.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. General

Colfax Corporation (the “Company” or “Colfax”) is a diversified global industrial manufacturing and engineering company that provides gas- and fluid-handling and fabrication technology products and services to customers around the world under the Howden, ESAB and Colfax Fluid Handling brand names. With the closing of the acquisition of Charter International plc (“Charter”) by Colfax (the “Charter Acquisition”) during the nine months ended September 28, 2012, Colfax has transformed from a fluid-handling business into a multi-platform enterprise with a global footprint. See Note 4, “Acquisitions” for additional information regarding the Charter Acquisition.

The Condensed Consolidated Financial Statements included in this quarterly report have been prepared by the Company in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements.

The Condensed Consolidated Balance Sheet as of December 31, 2011 is derived from the Company’s audited financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted in accordance with the SEC’s rules and regulations for interim financial statements. The Condensed Consolidated Financial Statements included herein should be read in conjunction with the audited financial statements and related footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011 (the “2011 Form 10-K”), filed with the SEC on February 23, 2012. Given the impact of the Charter Acquisition on the Condensed Consolidated Financial Statements, certain prior period amounts have been reclassified to conform to current year presentation.

The Condensed Consolidated Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Significant intercompany transactions and accounts are eliminated in consolidation.

The Company makes certain estimates and assumptions in preparing its Condensed Consolidated Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates.

The results of operations for the three and nine months ended September 28, 2012 are not necessarily indicative of the results of operations that may be achieved for the full year. Quarterly results are affected by seasonal variations in the Company’s gas- and fluid-handling business. As the Company’s customers seek to fully utilize capital spending budgets before the end of the year, historically shipments have peaked during the fourth quarter. General economic conditions as well as backlog levels may, however, impact future seasonal variations.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

2. Accounting Policies

During the nine months ended September 28, 2012, the Company’s significant accounting policies, as reflected in the 2011 Form 10-K, were updated to include the following as a result of the Charter Acquisition:

Revenue Recognition - Construction Contracts

The Company recognizes revenue and cost of sales on gas-handling construction projects using the “percentage of completion method” in accordance with GAAP. Under this method, contract revenues are recognized over the performance period of the contract in direct proportion to the costs incurred as a percentage of total estimated costs for the entirety of the contract. Any recognized revenues that have not been billed to a customer are recorded as a component of Trade receivables and any billings of customers in excess of recognized revenues are recorded as a component of Accounts payable. As of September 28, 2012, there were $148.3 million of revenues in excess of billings and $170.4 million of billings in excess of revenues on construction contracts in the Condensed Consolidated Balance Sheet.

The Company has contracts in various stages of completion. Such contracts require estimates to determine the appropriate cost and revenue recognition. Significant management judgments and estimates, including estimated costs to complete projects, must be made and used in connection with revenue recognized during each period. Current estimates may be revised as additional information becomes available. The revisions are recorded in income in the period in which they are determined using the cumulative catch-up method of accounting. See Note 16, “Segment Information” for sales by major product group.

Noncontrolling Interests

The Company’s Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. Less than wholly owned subsidiaries, including joint ventures, are consolidated when it is determined that the Company has a controlling financial interest, which is generally determined when the Company holds a majority voting interest. When protective rights, substantive rights or other factors exist, further analysis is performed in order to determine whether or not there is a controlling financial interest. The Condensed Consolidated Financial Statements reflect the assets, liabilities, revenues and expenses of consolidated subsidiaries and the noncontrolling parties’ ownership share is presented as a noncontrolling interest.

Derivatives

The Company is subject to foreign currency risk associated with the retranslation of the net assets of foreign subsidiaries to United States of America (“U.S.”) dollars on a periodic basis. The Company’s Deutsche Bank Credit Agreement (as defined and further discussed in Note 10, “Debt”) includes a €157.6 million term A-3 facility, which has been designated as a net investment hedge in order to mitigate a portion of this risk.

Derivative instruments are generally recognized on a gross basis in the Condensed Consolidated Balance Sheets in either Other current assets, Other assets, Accrued liabilities or Other liabilities depending upon their respective fair values and maturity dates. The Company designates a portion of its foreign exchange contracts as fair value hedges. For all instruments designated as hedges, including net investment hedges, cash flow hedges and fair value hedges, the Company formally documents the relationship between the hedging instrument and the hedged item, as well as the risk management objective and the strategy for using the hedging instrument. The Company assesses whether the relationship between the hedging instrument and the hedged item is highly effective at offsetting changes in the fair value both at inception of the hedging relationship and on an ongoing basis. For cash flow hedges and net investment hedges, unrealized gains and losses are recognized as a component of Accumulated other comprehensive loss in the Condensed Consolidated Balance Sheets to the extent that it is effective at offsetting the change in the fair value of the hedged item and realized gains and losses are recognized in the Condensed Consolidated Statements of Operations consistent with the underlying hedged instrument. Gains and losses related to fair value hedges are recorded as an offset to the fair value of the underlying asset or liability, primarily Trade receivables and Accounts payable in the Condensed Consolidated Balance Sheets.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

See Note 14, “Financial Instruments and Fair Value Measurements” for additional information regarding the Company’s derivative instruments.

Equity Method Investments

Investments in joint ventures, where the Company has a significant influence but not a controlling interest, are accounted for using the equity method of accounting. Investments accounted for under the equity method are initially recorded at the amount of the Company’s initial investment and adjusted each period for the Company’s share of the investee’s income or loss and dividends paid. All equity investments are reviewed periodically for indications of other than temporary impairment, including, but not limited to, significant and sustained decreases in quoted market prices or a series of historic and projected operating losses by investees. If the decline in fair value is considered to be other than temporary, an impairment loss is recorded and the investment is written down to a new carrying value. Investments in joint ventures acquired in the Charter Acquisition were recognized in the opening balance sheet at fair value. See Note 4, “Acquisitions” for additional information regarding the assets acquired in the Charter Acquisition.

3. Recently Issued Accounting Pronouncements

In July 2012, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2012-02, “Intangibles—Goodwill and Other” (“ASU No. 2012-02”). ASU No. 2012-02 is intended to reduce the cost and complexity of performing an impairment test for indefinite-lived intangible assets by permitting an entity first to assess qualitative factors to determine whether it is more likely than not that the fair value of an indefinite-lived intangible asset is less than its carrying amount. ASU No. 2012-02 is effective for interim and annual impairment tests performed for fiscal years beginning after September 15, 2012, with early adoption permitted. The Company intends to early adopt ASU No. 2012-02 in conjunction with its October 1, 2012 impairment analysis. The Company is currently evaluating the impact of adoption, but does not expect it to have a material impact on the Company’s Consolidated Financial Statements.

4. Acquisitions

Charter International plc

On January 13, 2012, Colfax completed the Charter Acquisition for a total purchase price of approximately $2.6 billion. Under the terms of the Charter Acquisition, Charter shareholders received 730 pence in cash and 0.1241 newly issued shares of Colfax Common stock in exchange for each share of Charter’s ordinary stock. Charter is a global industrial manufacturing company focused on welding, cutting and automation and air and gas handling. The acquisition is expected to:

•

enhance the Company’s business profile by providing a meaningful recurring revenue stream and considerable exposure to emerging markets;

•

enable Colfax to benefit from strong secular growth drivers, with a balance of short- and long-cycle businesses; and

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

•

provide an additional growth platform in the fragmented fabrication technology industry.

See Note 10, “Debt” and Note 11, “Equity” for a discussion of the respective financing components of the Charter Acquisition.

In connection with the Charter acquisition the Company incurred advisory, legal, valuation and other professional service fees, termination payments to Charter executives and realized losses on acquisition-related foreign exchange derivatives, which comprised Charter acquisition-related expense in the Condensed Consolidated Statements of Operations.

See Note 14, “Financial Instruments and Fair Value Measurements” for additional information regarding the Company’s derivative instruments.

The Charter Acquisition was accounted for using the acquisition method of accounting and accordingly, the Condensed Consolidated Financial Statements include the financial position and results of operations from the date of acquisition. The following unaudited proforma financial information presents Colfax’s consolidated financial information assuming the acquisition had taken place on January 1, 2011. These amounts are presented in accordance with GAAP, consistent with the Company’s accounting policies.

	Three Months Ended					Nine Months Ended
	September 28, 2012		September 30, 2011			September 28, 2012		September 30, 2011
	(Unaudited, in thousands)
Net sales	$	954,440	$	973,680		$	2,955,884	$	2,847,695
Net income (loss) available to Colfax common shareholders⁽¹⁾		18,892		(23,355	)		56,087		(132,605	)

__________

⁽¹⁾

Proforma net loss available to Colfax common shareholders for the three and nine months ended September 30, 2011 reflect the impact of certain expenses included in the Condensed Consolidated Statements of Operations for the three and nine months ended September 28, 2012, but excluded from the calculation of proforma net income for that period. These expenses include increased acquisition-related amortization expense of $14.5 million and $62.6 million for the three and nine months ended September 30, 2011, respectively. Additionally, the nine months ended September 30, 2011 include $43.6 million of Charter acquisition-related expense and a $50.3 million increase in the valuation allowance related to the Company’s deferred tax assets in the U.S., discussed further in Note 7, “Income Taxes.”

The following table summarizes the Company’s best estimate of the aggregate fair value of the assets acquired and liabilities assumed at the date of acquisition. These amounts are determined based upon certain valuations and studies that have yet to be finalized, and accordingly, the assets acquired and liabilities assumed, as detailed below, are subject to adjustment once the detailed analyses are completed. There is also a required change of control payment related to a defined benefit pension plan which is based on plan provisions which must be interpreted by an actuary. Such interpretation and the related financial statement impact have not yet been received. During the measurement period, the Company has made aggregate retrospective adjustments of $5.8 million and $18.0 million during the three and nine months ended September 28, 2012, respectively, to provisional amounts related to the Charter Acquisition that were recognized at the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. The aggregate adjustments increased the Goodwill balance and primarily relate to the Company’s valuation of inventory and the related deferred tax impact. Substantially all of the Goodwill recognized is not expected to be deductible for income tax purposes.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

	January 13,
	2012
	(In thousands)
Trade receivables	$	686,211
Inventories		452,325
Property, plant and equipment		563,333
Goodwill		1,613,440
Intangible assets		715,643
Accounts payable		(375,393	)
Debt		(398,705	)
Other assets and liabilities, net		(468,546	)
		2,788,308
Less: net assets attributable to noncontrolling interest		(236,257	)
Net consideration	$	2,552,051

The following table summarizes Intangible assets acquired, excluding Goodwill, as of January 13, 2012:

	Intangible		Weighted-Average
	Asset		Amortization
	(In thousands)		Period (Years)
Trade names – indefinite life	$	363,628		n/a
Customer relationships		215,310		7.10
Acquired technology		77,485		10.33
Backlog		54,805		1.00
Trademarks		4,415		5.00
Intangible assets	$	715,643		6.84

Co-Vent

On September 13, 2012, the Company completed the acquisition of the common stock of Co-Vent Group Inc. (“Co-Vent”) for $32.3 million. Co-Vent specializes in the custom design, manufacture, and testing of industrial fans, with its primary operations based in Quebec, Canada. As a result of this acquisition, the Company has expanded its product offerings in the industrial fan market.

Soldex

On May 26, 2012, the Company entered into a share purchase agreement with Inversiones Breca S.A. to acquire an interest of approximately 91% of Soldex S.A. (“Soldex”) for approximately $183.4 million. Soldex is organized under the laws of Peru and will complement our existing fabrication technology segment by supplying welding products from its plants in Colombia and Peru. The acquisition of Soldex is subject to certain regulatory approvals and is currently expected to close during the fourth quarter of 2012.

Other

On April 13, 2012, the Company completed a $29.3 million acquisition of shares in ESAB India Limited, a publicly traded, less than wholly owned subsidiary in which the Company acquired a controlling interest in the Charter Acquisition. This resulted in an increase in the Company’s ownership of the subsidiary from 56% to 74%. This acquisition of shares was pursuant to a statutorily mandated tender offer triggered as a result of the Charter Acquisition.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

In May 2012, the Company completed an $8.5 million acquisition, including the assumption of debt, of the remaining ownership of CJSC Sibes (“Sibes”), a less than wholly owned subsidiary in which the Company did not have a controlling interest. This resulted in an increase in the Company’s ownership of Sibes from 16% to 100%.

5. Goodwill and Intangible Assets

The following table summarizes the activity in Goodwill, by segment, during the nine months ended September 28, 2012:

	Gas and Fluid Handling		Fabrication Technology		Total
	(In thousands)
Balance, January 1, 2012	$	204,844	$	—	$	204,844
Goodwill attributable to Charter Acquisition		931,303		682,137		1,613,440
Goodwill attributable to Co-Vent acquisition		18,947		—		18,947
Goodwill attributable to other acquisitions		596		5,699		6,295
Impact of foreign currency translation		49,879		36,031		85,910
Balance, September 28, 2012	$	1,205,569	$	723,867	$	1,929,436

The following table summarizes the Intangible assets, excluding Goodwill:

	September 28, 2012					December 31, 2011
	Gross Carrying Amount		Accumulated Amortization			Gross Carrying Amount		Accumulated Amortization
	(In thousands)
Trade names – indefinite life	$	392,378	$	—		$	6,803	$	—
Acquired customer relationships		256,628		(21,165	)		29,798		(12,987	)
Acquired technology		105,028		(9,567	)		17,961		(2,791	)
Acquired backlog		63,606		(45,606	)		3,451		(2,033	)
Other intangible assets		9,487		(5,206	)		4,962		(4,135	)
	$	827,127	$	(81,544	)	$	62,975	$	(21,946	)

See Note 4, “Acquisitions” for additional information regarding the activity in Goodwill and intangible assets associated with the Charter Acquisition.

Amortization expense related to amortizable intangible assets was included in Selling, general and administrative expense in the Condensed Consolidated Statements of Operations as follows:

	Three Months Ended				Nine Months Ended
	September 28, 2012		September 30, 2011		September 28, 2012		September 30, 2011
	(In thousands)
Amortization expense	$	21,381	$	1,873	$	61,691	$	6,224

Total amortization expense for amortizable intangible assets as of September 28, 2012 is expected to be $37.0 million, $35.2 million, $33.6 million, $33.5 million and $29.9 million for the years ended December 31, 2013, 2014, 2015, 2016 and 2017, respectively.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

6. Net Income (Loss) Per Share

Net income (loss) per share available to Colfax Corporation common shareholders was computed under the two-class method as follows:

	Three Months Ended				Nine Months Ended
	September 28, 2012		September 30, 2011		September 28, 2012			September 30, 2011
	(In thousands, except share data)
Net income (loss) available to Colfax Corporation common shareholders	$	4,022	$	3,690	$	(98,017	)	$	20,635
Less: net income attributable to participating securities⁽¹⁾		517		—		—			—
	$	3,505	$	3,690	$	(98,017	)	$	20,635

Weighted-average shares of Common stock outstanding— basic		94,040,440		43,682,698		90,003,515			43,598,692
Net effect of potentially dilutive securities⁽²⁾		751,488		729,272		—			700,465
Weighted-average shares of Common stock outstanding— diluted		94,791,928		44,411,970		90,003,515			44,299,157
Net income (loss) per share—basic and diluted	$	0.04	$	0.08	$	(1.09	)	$	0.47

__________

⁽¹⁾

Net income (loss) per share was calculated consistent with the two-class method in accordance with GAAP as the shares of the Company’s Series A Preferred Stock are considered participating securities.

⁽²⁾

Potentially dilutive securities consist of stock options and restricted stock units.

The weighted-average computation of the dilutive effect of potentially issuable shares of Common stock under the treasury stock method for the three months ended September 28, 2012 and September 30, 2011 excludes approximately 1.4 million and 0.5 million outstanding stock-based compensation awards, respectively, as their inclusion would be anti-dilutive. The weighted-average computation of the dilutive effect of potentially issuable shares of Common stock under the treasury stock method for the nine months ended September 28, 2012 and September 30, 2011 excludes approximately 2.8 million and 0.5 million outstanding stock-based compensation awards, respectively, as their inclusion would be anti-dilutive.

7. Income Taxes

During the three months ended September 28, 2012, Income before income taxes was $28.1 million and the Provision for income taxes was $13.6 million. The Provision for income taxes for the three months ended September 28, 2012 was significantly impacted by corporate overhead and Interest expense related to the combined organization reflected in the Condensed Consolidated Statement of Operations, which were incurred in jurisdictions where no tax benefit can be recognized. These items were partially offset by a discrete credit to income tax expense of $2.9 million from a reduction to deferred tax balances in the United Kingdom associated with the enactment of lower corporate tax rates.

During the nine months ended September 28, 2012, Income before income taxes was $19.6 million and the Provision for income taxes was $86.9 million, which was impacted by two significant items. Upon completion of the Charter Acquisition, certain deferred tax assets existing at that date were reassessed in light of the impact of the acquired businesses on expected future income or loss by country and future tax planning, including the impact of the post-acquisition capital structure. This assessment resulted in an increase in the Company’s valuation allowance to provide full valuation allowances against U.S. deferred tax assets. The increased valuation allowances resulted in an increase to the Provision for income taxes for the nine months ended September 28, 2012 of $50.3 million. In addition, $43.6 million of Charter acquisition-related expense and increased corporate overhead and Interest expense reflected in the Condensed Consolidated Statement of Operations are either non-deductible or were incurred in jurisdictions where no tax benefit can be recognized. These two items are the principal cause of an effective tax rate significantly higher than the U.S. federal statutory rate.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

During the three and nine months ended September 30, 2011, Income before income taxes was $4.2 million and $29.0 million, respectively, and the Provision for income taxes was $0.5 million and $8.3 million, respectively. The effective tax rates of 12.6% and 28.8% for the three and nine months ended September 30, 2011, respectively, differ from the U.S. federal statutory tax rate primarily due to international tax rates, which are lower than the U.S. tax rate, and changes in the estimated annual tax rate. The estimated annual tax rate declined primarily due to the impact of changes in anticipated pre-tax income for the year ended December 31, 2011 in various tax jurisdictions that the Company operates in. The cumulative impact of this adjustment during the three months ended September 30, 2011 resulted in an effective tax rate of 12.6%. The change in the estimated annual tax rate resulted in an increase of approximately $0.7 million in Net income for both the three and nine months ended September 30, 2011, or $0.01 and $0.02 per share, respectively.

In accordance with GAAP, the Company records a liability for unrecognized income tax benefits for the amount of benefit included in its previously filed income tax returns and in its financial results expected to be included in income tax returns to be filed for periods through the date of its Condensed Consolidated Financial Statements for income tax positions for which it is more likely than not that a tax position will not be sustained upon examination by the respective taxing authority. A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows:

	(In thousands)
Balance, January 1, 2012		4,077
Addition for tax positions taken in prior periods		1,478
Addition for tax positions taken in the current period		3,349
Addition related to acquired entities		71,760
Other, including the impact of foreign currency translation		3,839
Balance, September 28, 2012	$	84,503

The Company is now subject to income tax in more than 100 countries and is routinely examined by tax authorities around the world. Tax examinations for years dating back to 1999 remain in process in multiple countries.

The Company’s total unrecognized tax benefits were $84.5 million and $4.1 million as of September 28, 2012 and December 31, 2011, respectively, inclusive of $16.7 million and $0.4 million, respectively, of interest and penalties. These amounts were offset in part by tax benefits of $0.5 million as of both September 28, 2012 and December 31, 2011. The net liabilities for uncertain tax positions as of September 28, 2012 and December 31, 2011 were $84.0 million and $3.6 million, respectively, and if recognized, would favorably impact the effective tax rate. The Company records interest and penalties on uncertain tax positions as a component of Provision for income taxes, which was $0.6 million and $0.1 million for the three months ended September 28, 2012 and September 30, 2011, respectively. Interest and penalties on uncertain tax positions for the nine months ended September 28, 2012 and September 30, 2011 were $1.5 million and $0.2 million, respectively.

Due to the difficulty in predicting with reasonable certainty when tax audits will be fully resolved and closed, the range of reasonably possible significant increases or decreases in the liability for unrecognized tax benefits that may occur within the next 12 months is difficult to ascertain. Currently, the Company estimates that it is reasonably possible that the expiration of various statutes of limitations and resolution of tax audits may reduce its tax expense in the next 12 months up to $2.2 million.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

The Charter Acquisition materially impacted the Company’s deferred tax assets, liabilities and valuation allowances. Significant components of the deferred tax assets and liabilities as of January 13, 2012 are estimated as follows:

	January 13, 2012
	Current			Non-Current
	(In thousands)
Deferred tax assets:
Post-retirement benefit obligation	$	1,474		$	106,948
Expenses currently not deductible		45,048			71,981
Net operating loss carryover		20,220			130,476
Tax credit carryover		—			15,482
Other		9,340			27,005
Total deferred tax assets		76,082			351,892
Valuation allowance		(21,588	)		(241,509	)
Deferred tax assets, net	$	54,494		$	110,383

Deferred tax liabilities:
Depreciation and amortization	$	—		$	58,055
Pension		—			22,022
Intangible assets		6,699			196,377
Other		1,721			27,749
Total deferred tax liabilities	$	8,420		$	304,203

Total deferred tax assets (liabilities), net	$	46,074		$	(193,820	)

Acquired subsidiaries with significant noncontrolling interests in India, South Africa and China as well as a wholly owned Russian subsidiary are expected to remit dividends. Consequently, a liability of $12.5 million has been established as of September 28, 2012. All other undistributed earnings of the Company’s controlled international subsidiaries are considered to be permanently reinvested and no tax expense in the U.S. has been recognized under the applicable accounting standard for these reinvested earnings. The amount of deferred tax liability that would have been recognized had such earnings not been permanently reinvested is not reasonably determinable.

8. Property, Plant and Equipment, Net

	Depreciable Life	September 28, 2012			December 31, 2011
	(In years)	(In thousands)
Land	n/a	$	30,808		$	14,786
Buildings and improvements	5-40		303,688			38,642
Machinery and equipment	3-15		425,622			134,548
Software	3-5		68,279			16,948
			828,397			204,924
Accumulated depreciation			(166,103	)		(113,985	)
Property, plant and equipment, net		$	662,294		$	90,939

Depreciation expense, including the amortization of assets recorded under capital leases, consisted of the following:

	Three Months Ended				Nine Months Ended
	September 28, 2012		September 30, 2011		September 28, 2012		September 30, 2011
	(In thousands)
Total depreciation expense	$	17,834	$	3,228	$	52,251	$	9,593
Depreciation expense related to software		2,679		406		7,540		1,248

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

9. Inventories, Net

Inventories, net consisted of the following:

	September 28,			December 31,
	2012			2011
	(In thousands)
Raw materials	$	165,079		$	25,241
Work in process		107,620			26,376
Finished goods		266,566			20,378
		539,265			71,995
Less: customer progress billings		(11,425	)		(9,124	)
Less: allowance for excess, slow-moving and obsolete inventory		(8,482	)		(6,735	)
Inventories, net	$	519,358		$	56,136

10. Debt

Long-term debt consisted of the following:

	September 28,			December 31,
	2012			2011
	(In thousands)
Term loans	$	1,675,466		$	72,500
Revolving credit facilities and other		17,637			39,018
Total Debt		1,693,103			111,518
Less: current portion		(34,033	)		(10,000	)
Long-term debt	$	1,659,070		$	101,518

As of December 31, 2011, the Company was party to a credit agreement (the “Bank of America Credit Agreement”), led and administered by Bank of America, which was a senior secured structure with a revolving credit facility and term credit facility. The term credit facility bore interest at the London Interbank Offered Rate (“LIBOR”) plus a margin ranging from 2.25% to 2.75% determined by the total leverage ratio calculated at the end of each quarter. As of December 31, 2011, the interest rate was 2.55% inclusive of a margin of 2.25%. Additionally, an annual commitment fee on the revolver ranged from 40 basis points to 50 basis points determined by the Company’s total leverage ratio calculated at the end of each quarter. As of December 31, 2011, the commitment fee was 40 basis points and there was $21.0 million outstanding on the letter of credit sub-facility.

During the nine months ended September 28, 2012, the Company terminated the Bank of America Credit Agreement in conjunction with the financing of the Charter Acquisition. Upon the early termination of the Bank of America Credit Agreement, the Company incurred a total pre-tax charge of $1.5 million, which includes the write-off of $1.0 million of deferred financing fees and $0.5 million of losses reclassified from Accumulated other comprehensive loss in the Condensed Consolidated Balance Sheet for the related interest rate swap to Interest expense in the Condensed Consolidated Statement of Operations.

On January 13, 2012 and January 25, 2012, Colfax incurred debt consisting of: (i) a $200 million term A-1 facility, (ii) a $500 million term A-2 facility, (iii) a €157.6 million term A-3 facility and (iv) a $900 million term B facility pursuant to a credit agreement (the “Deutsche Bank Credit Agreement”) with Deutsche Bank Securities Inc., HSBC Securities (USA) Inc. and certain other lender parties named therein. In addition, the Deutsche Bank Credit Agreement has two revolving credit facilities which total $300 million in commitments (the “Revolver”). The Revolver includes a $200 million letter of credit sub-facility and a $50 million swingline loan sub-facility. The term A-1, term A-2, term A-3 and the Revolver variable-rate borrowings are subject to interest payments of LIBOR or the Euro Interbank Offered Rate (“EURIBOR”) plus a margin ranging from 2.50% to 3.25%, determined by our leverage ratio. Borrowings under the term B facility are also variable rate and are subject to interest payments of LIBOR plus a margin of 3.5%. The Revolver is subject to a commitment fee ranging from 37.5 and 50 basis points, determined by the Company’s leverage ratio. Additionally, as of September 28, 2012 the Company had an original issue discount of $59.3 million and deferred financing fees of $9.3 million, which were recognized in connection with the Deutsche Bank Credit Agreement, and will be accreted to Interest expense primarily using the effective interest method. The weighted-average interest rate of borrowings under the Deutsche Bank Credit Agreement for the nine months ended September 28, 2012 was 3.87% and there was $291.9 million available on the Revolver, including $191.9 available on the letter of credit sub-facility.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

The Company is also party to additional letter of credit facilities with total capacity of $474.2 million and $338.6 million outstanding as of September 28, 2012.

The contractual maturities of the Company’s debt as of September 28, 2012 are as follows⁽¹⁾:

	(In thousands)
Remainder of 2012	$	19,783
2013		19,138
2014		118,165
2015		189,553
2016		415,244
2017		144,415
Thereafter		846,102
Total contractual maturities		1,752,400
Debt discount		(59,297	)
Total debt	$	1,693,103

__________

⁽¹⁾ Represents scheduled payments required under the Deutsche Bank Credit Agreement through the respective final maturities of the term A facilities through January 13, 2017 and the term B facility through January 13, 2019, as well as the contractual maturities of other debt outstanding as of September 28, 2012.

In March 2012, the Company used a portion of the proceeds from the sale of Common stock to pay off $35.0 million in borrowings under the term A facilities in advance of the scheduled payments. In June 2012, the Company repaid an additional $26.3 million in borrowings under the term A facilities in advance of the scheduled payments. See Note 11, “Equity” for additional discussion regarding the Company’s stock issuances.

In connection with the Deutsche Bank Credit Agreement, the Company has pledged substantially all of its domestic subsidiaries’ assets and 65% of the shares of certain first tier international subsidiaries as collateral against borrowings to its U.S. companies. In addition, subsidiaries in certain foreign jurisdictions have guaranteed the Company’s obligations on borrowings of one of its European subsidiaries, as well as pledged substantially all of their assets for such borrowings to this European subsidiary under the Deutsche Bank Credit Agreement. The Deutsche Bank Credit Agreement contains customary covenants limiting the Company’s ability to, among other things, pay dividends, incur debt or liens, redeem or repurchase equity, enter into transactions with affiliates, make investments, merge or consolidate with others or dispose of assets. In addition, the Deutsche Bank Credit Agreement contains financial covenants requiring the Company to maintain a total leverage ratio, as defined therein, of not more than 4.95 to 1.0 and a minimum interest coverage ratio, as defined therein, of 2.0 to 1.0, measured at the end of each quarter, through the year ended December 31, 2012. The minimum interest coverage ratio increases by 25 basis points each year beginning in the year ended December 31, 2013 until it reaches 3.0 to 1.0 for the year ended December 31, 2016. The maximum total leverage ratio decreases to 4.75 to 1.0 for the year ended December 31, 2014 and decreases by 25 basis points for the two subsequent fiscal years until it reaches 4.25 to 1.0 for the year ended December 31, 2016. The Deutsche Bank Credit Agreement contains various events of default, including failure to comply with such financial covenants, and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the term loans and the Revolver and foreclose on the collateral. The Company is in compliance with all such covenants as of September 28, 2012.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

11. Equity

Common and Preferred Stock

On January 24, 2012, following approval by the Company’s shareholders, the Company’s Certificate of Incorporation was amended to increase the number of authorized shares from 210,000,000 shares to 420,000,000 shares, comprised of an increase in Common stock from 200,000,000 shares to 400,000,000 shares and an increase in Preferred stock from 10,000,000 shares to 20,000,000 shares.

In connection with the financing of the Charter Acquisition, on January 24, 2012, the Company sold (i) 14,756,945 shares of newly issued Colfax Common stock and (ii) 13,877,552 shares of newly created Series A perpetual convertible preferred stock, referred to as the Series A Preferred Stock, for an aggregate of $680 million (representing $24.50 per share of Series A Preferred Stock and $23.04 per share of Common stock) pursuant to a securities purchase agreement with BDT CF Acquisition Vehicle, LLC (the “BDT Investor”) as well as BDT Capital Partners Fund I-A, L.P., and Mitchell P. Rales, Chairman of Colfax’s Board of Directors, and his brother, Steven M. Rales (for the limited purpose of tag-along sales rights provided to the BDT Investor in the event of a sale or transfer of shares of Colfax Common stock by either or both of Mitchell P. Rales and Steven M. Rales). Under the terms of the Series A Preferred Stock, holders are entitled to receive cumulative cash dividends, payable quarterly, at a per annum rate of 6% of the liquidation preference (defined as $24.50, subject to customary antidilution adjustments), provided that the dividend rate shall be increased to a per annum rate of 8% if the Company fails to pay the full amount of any dividend required to be paid on such shares until the date that full payment is made.

The Series A Preferred Stock is convertible, in whole or in part, at the option of the holders at any time after the date the shares were issued into shares of Colfax Common stock at a conversion rate determined by dividing the liquidation preference by a number equal to 114% of the liquidation preference, subject to certain adjustments. The Series A Preferred Stock is also convertible, in whole or in part, at the option of Colfax on or after the third anniversary of the issuance of the shares at the same conversion rate if, among other things: (i) for the preceding thirty trading days, the closing price of Colfax Common stock on the New York Stock Exchange exceeds 133% of the applicable conversion price and (ii) Colfax has declared and paid or set apart for payment all accrued but unpaid dividends on the Series A Preferred Stock.

On January 24, 2012, Colfax sold 2,170,139 shares of newly issued Colfax Common stock to each of Mitchell P. Rales, Chairman of Colfax’s Board of Directors, and his brother Steven M. Rales and 1,085,070 shares of newly issued Colfax Common stock to Markel Corporation, a Virginia corporation (“Markel”) at $23.04 per share, for an aggregate of $125 million, pursuant to separate securities purchase agreements with Mitchell P. Rales and Steven M. Rales, each of whom were beneficial owners of 20.9% of Colfax’s Common stock, and Markel. Thomas S. Gayner, a member of Colfax’s Board of Directors, is President and Chief Investment Officer of Markel.

Consideration paid to Charter shareholders included 0.1241 shares of newly issued Colfax Common stock in exchange for each share of Charter’s ordinary stock, which resulted in the issuance of 20,735,493 shares of Common stock on January 24, 2012.

In conjunction with the issuance of the Common and Preferred stock discussed above, the Company recognized $14.7 million in equity issuance costs which were recorded as a reduction to Additional paid-in capital during the nine months ended September 28, 2012.

On March 5, 2012, the Company sold 8,000,000 shares of newly issued Colfax Common stock to underwriters for public resale pursuant to a shelf registration statement for an aggregate purchase price of $272 million. Further, on March 9, 2012, the underwriters of the March 5, 2012 equity offering exercised their over-allotment option and the Company sold an additional 1,000,000 shares of newly issued Colfax Common stock to the underwriters for public resale pursuant to a shelf registration statement for an aggregate purchase price of $34 million. In conjunction with these issuances, the Company recognized $12.6 million in equity issuance costs which were recorded as a reduction to Additional paid-in capital during the nine months ended September 28, 2012.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

Dividend Restrictions

The Company is subject to dividend restrictions under the Deutsche Bank Credit Agreement, which limit the total amount of cash dividends the Company may pay and Common stock repurchases the Company may make to $50 million annually, in the aggregate.

Accumulated Other Comprehensive Loss

The activity in the components of Accumulated other comprehensive loss during the nine months ended September 28, 2012 is as follows:

	Foreign Currency Translation Adjustment(1)			Unrealized Losses on Hedging Activities			Net Unrecognized Pension and Other Post- Retirement Benefit Cost			Accumulated Other Comprehensive Loss
	(In millions)
Balance at January 1, 2012	$	(5,537	)	$	(471	)	$	(164,785	)	$	(170,793	)
ESAB India repurchase of additional noncontrolling interest		(2,644	)		—			—			(2,644	)
Change during 2012		86,341			(277	)		6,232			92,296
Balance at September 28, 2012	$	78,160		$	(748	)	$	(158,553	)	$	(81,141	)

__________

⁽¹⁾

The activity in Accumulated other comprehensive loss related to foreign currency translation for the nine months ended September 28, 2012 excludes the $(4.5) million impact of foreign currency translation related to Noncontrolling interest during the period.

Share-Based Payments

The Company measures and recognizes compensation expense related to share-based payments based on the fair value of the instruments issued. Stock-based compensation expense is generally recognized as a component of Selling, general and administrative expense in the Condensed Consolidated Statements of Operations, as payroll costs of the employees receiving the awards are recorded in the same line item.

The Condensed Consolidated Statements of Operations reflect the following amounts related to stock-based compensation:

	Three Months Ended				Nine Months Ended
	September 28, 2012		September 30, 2011		September 28, 2012		September 30, 2011
	(In thousands)
Stock-based compensation expense	$	2,441	$	1,058	$	6,429	$	3,885
Deferred tax benefits		145		371		386		1,360

As of September 28, 2012, the Company had $24.1 million of unrecognized compensation expense related to stock-based awards that will be recognized over a weighted-average period of approximately 2.4 years.

Stock Options

Stock-based compensation expense for stock option awards is based upon the grant-date fair value using the Black-Scholes option pricing model. The Company recognizes compensation expense for stock option awards on a ratable basis over the requisite service period of the entire award. The following table shows the weighted-average assumptions used to calculate the fair value of stock option awards using the Black-Scholes option pricing model, as well as the weighted-average fair value of options granted:

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

	Nine Months Ended
	September 28, 2012

Expected period that options will be outstanding (in years)		5.49
Interest rate (based on U.S. Treasury yields at the time of grant)		1.03	%
Volatility		42.14	%
Dividend yield		—
Weighted-average fair value of options granted	$	12.94

Expected volatility is estimated based on the historical volatility of comparable public companies. The Company considers historical data to estimate employee termination within the valuation model. Separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. Since the Company has limited option exercise history, it has generally elected to estimate the expected life of an award based upon the SEC-approved “simplified method” noted under the provisions of Staff Accounting Bulletin No. 107 with the continued use of this method extended under the provisions of Staff Accounting Bulletin No. 110.

Stock option activity is as follows:

	Number of Options			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (In years)		Aggregate Intrinsic Value⁽¹⁾ (In thousands)
Outstanding at December 31, 2011		1,461,157			14.76
Granted		1,119,070			32.86
Exercised		(338,157	)		12.75
Forfeited		(42,878	)		29.88
Expired		(11,992	)		13.55
Outstanding at September 28, 2012		2,187,200		$	24.04		5.47	$	27,623
Vested or expected to vest at September 28, 2012		2,222,236		$	23.94		5.45	$	28,296
Exercisable at September 28, 2012		688,160		$	14.09		4.09	$	15,266

__________

⁽¹⁾

The aggregate intrinsic value is based upon the difference between the Company’s closing stock price at the date of the Consolidated Balance Sheet and the exercise price of the stock option for in-the-money stock options. The intrinsic value of outstanding stock options fluctuates based upon the trading value of the Company’s Common stock.

Restricted Stock Units

The fair value of performance-based restricted stock units (“PRSUs”) and restricted stock units (“RSUs”) is equal to the market value of a share of Common stock on the date of grant, and the related compensation expense is recognized ratably over the requisite service period and, for PRSUs, when it is expected that any of the performance criterion will be achieved.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

The activity in the Company’s PRSUs and RSUs is as follows:

	PRSUs					RSUs
	Number of Units			Weighted- Average Grant Date Fair Value		Number of Units			Weighted- Average Grant Date Fair Value
Nonvested at December 31, 2011		324,447		$	15.99		64,263		$	14.71
Granted		283,804			33.48		21,259			23.07
Vested		(17,942	)		18.11		(41,341	)		12.74
Forfeited		(16,761	)		22.37		—			—
Nonvested at September 28, 2012		573,548		$	24.39		44,181		$	23.36

12. Accrued Liabilities

Accrued liabilities in the Condensed Consolidated Balance Sheets consisted of the following:

	September 28, 2012		December 31, 2011
	(In thousands)
Accrued payroll	$	103,448	$	21,415
Advance payment from customers		77,803		14,704
Accrued taxes		105,922		4,911
Accrued asbestos-related liability		66,505		76,295
Warranty liability – current portion		36,892		2,987
Accrued restructuring liability – current portion		20,528		4,573
Accrued pension liability		17,391		1,267
Accrued interest		10,494		75
Accrued third-party commissions		11,575		5,884
Accrued Charter Acquisition-related liability		506		29,430
Other		98,996		14,466
Accrued liabilities	$	550,060	$	176,007

Warranty Liability

Estimated expenses related to product warranties are accrued at the time products are sold to customers and included in Cost of sales in the Condensed Consolidated Statements of Operations. Estimates are established using historical information as to the nature, frequency, and average costs of warranty claims.

The activity in the Company’s warranty liability consisted of the following:

	Nine Months Ended
	September 28,			September 30,
	2012			2011
	(In thousands)
Warranty liability, beginning of period	$	2,987		$	2,963
Accrued warranty expense		9,728			2,278
Changes in estimates related to pre-existing warranties		15			684
Cost of warranty service work performed		(18,200	)		(1,777	)
Acquisitions		47,341			452
Foreign exchange translation effect		(1,300	)		22
Warranty liability, end of period	$	40,571		$	4,622

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

Accrued Restructuring Liability

The Company initiated a series of restructuring actions at its fluid-handling operations beginning in 2009 in response to then current and expected future economic conditions. During the nine months ended September 30, 2011, the Company also relocated its Richmond, Virginia corporate headquarters to Fulton, Maryland.

As a result of the Charter Acquisition, the Company’s restructuring programs expanded to include ongoing initiatives at the Company’s fabrication technology operations and efforts to reduce the structural costs and rationalize the corporate overhead of the combined businesses. Initiatives at the Company’s fabrication technology operations include the transfer of European capacity, a reduction in fixed overhead in Europe and the replacement of an old factory in the U.S. with a modern, lower cost and higher capacity facility.

The Condensed Consolidated Statements of Operations reflect the following amounts related to the Company’s restructuring activities:

	Three Months Ended				Nine Months Ended
	September 28, 2012		September 30, 2011		September 28, 2012		September 30, 2011⁽¹⁾
	(In thousands)
Restructuring and other related charges	$	15,865	$	5,299	$	43,066	$	7,518

__________

⁽¹⁾

Includes $0.2 million of non-cash stock-based compensation expense.

A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Condensed Consolidated Balance Sheets is as follows:

	Nine Months Ended September 28, 2012
	Balance at Beginning of Period		Acquisitions		Provisions		Payments			Foreign Currency Translation		Balance at End of Period
	(In thousands)
Restructuring and other related charges:
Termination benefits⁽¹⁾	$	3,868	$	6,191	$	30,054	$	(23,109	)	$	463	$	17,467
Facility closure costs⁽²⁾		633		3,974		4,113		(3,136	)		62		5,646
Other related charges		72		—		5,951		(6,106	)		129		46
	$	4,573	$	10,165		40,118	$	(32,351	)	$	654	$	23,159
Non-cash impairment						2,948
					$	43,066

__________

⁽¹⁾

Includes severance and other termination benefits, including outplacement services. The Company recognizes the cost of involuntary termination benefits at the communication date or ratably over any remaining expected future service period. Voluntary termination benefits are recognized as a liability and an expense when employees accept the offer and the amount can be reasonably estimated.

⁽²⁾

Includes the cost of relocating and training associates, relocating equipment and lease termination expense in connection with the closure of facilities, discussed above.

The Company expects to incur Restructuring and other related charges of approximately $8.0 million during the remainder of 2012 related to these restructuring activities.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

13. Net Periodic Benefit Cost–Defined Benefit Plans

In conjunction with the Charter Acquisition, the Company acquired a net pension and other post-retirement benefit liability of $206.0 million as of January 13, 2012 and increased its pension and other post-retirement benefit plans by 44 plans. Of the total plans acquired, 40 were underfunded by a total amount of $256.8 million and three were overfunded by a total amount of $50.8 million. Employer contributions to pension and other post-retirement employee benefit plans during the nine months ended September 28, 2012 were $50.3 million, and the Company expects to make additional contributions ranging from $5 million to $15 million during the remainder of the year ending December 31, 2012. Contributions during the nine months ended September 28, 2012 included $18.9 million of supplemental contributions to pension plans in the United Kingdom as a result of financing the Charter Acquisition. See Note 4, “Acquisitions” for additional information regarding the Charter Acquisition.

The following table sets forth the components of net periodic benefit cost of the defined benefit pension plans and the Company’s other post-retirement employee benefit plans:

	Three Months Ended						Nine Months Ended
	September 28, 2012			September 30, 2011			September 28, 2012			September 30, 2011
	(In thousands)
Pension Benefits—U.S. Plans:
Service cost	$	—		$	—		$	—		$	—
Interest cost		4,699			2,845			14,044			8,537
Expected return on plan assets		(6,050	)		(4,164	)		(18,093	)		(12,493	)
Amortization		1,800			1,313			5,400			3,939
Net periodic benefit cost (credit)	$	449		$	(6	)	$	1,351		$	(17	)

Pension Benefits—Non U.S. Plans:
Service cost	$	828		$	304		$	2,388		$	926
Interest cost		8,221			1,255			24,322			3,742
Expected return on plan assets		(4,726	)		(354	)		(14,216	)		(1,070	)
Amortization		184			151			564			464
Settlement loss⁽¹⁾		—			—			—			1,499
Net periodic benefit cost	$	4,507		$	1,356		$	13,058		$	5,561

Other Post-Retirement Benefits:
Service cost	$	50		$	—		$	152		$	—
Interest cost		310			172			949			517
Amortization		232			214			698			640
Net periodic benefit cost	$	592		$	386		$	1,799		$	1,157

__________

⁽¹⁾

During the nine months ended September 30, 2011, the Company terminated a frozen pension plan of one of its non-U.S. subsidiaries.

14. Financial Instruments and Fair Value Measurements

The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair value of the Company’s debt of $1.7 billion and $110.9 million as of September 28, 2012 and December 31, 2011, respectively, was based on current interest rates for similar types of borrowings and is in Level Two of the fair value hierarchy. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

A summary of the Company’s assets and liabilities that are measured at fair value on a recurring basis for each fair value hierarchy level for the periods presented follows:

	September 28, 2012
	Level One		Level Two		Level Three		Total
	(In thousands)
Assets:
Cash equivalents	$	219,068	$	—	$	—	$	219,068
Foreign currency contracts related to sales – designated as hedges		—		5,564		—		5,564
Foreign currency contracts related to sales – not designated as hedges		—		3,301		—		3,301
Foreign currency contracts related to purchases – designated as hedges		—		366		—		366
Foreign currency contracts related to purchases – not designated as hedges		—		859		—		859
Deferred compensation plans		—		2,411		—		2,411
	$	219,068	$	12,501	$	—	$	231,569

Liabilities:
Foreign currency contracts related to sales – designated as hedges	$	—	$	2,271	$	—	$	2,271
Foreign currency contracts related to sales – not designated as hedges		—		2,888		—		2,888
Foreign currency contracts related to purchases – designated as hedges		—		1,154		—		1,154
Foreign currency contracts related to purchases – not designated as hedges		—		864		—		864
Deferred compensation plans		—		2,411		—		2,411
Liability for contingent payments		—		—		4,893		4,893
	$	—	$	9,588	$	4,893	$	14,481

	December 31, 2011
	Level One		Level Two		Level Three		Total
	(In thousands)
Assets:
Cash equivalents	$	15,540	$	—	$	—	$	15,540
Foreign currency contracts – primarily related to customer sales contracts		—		5		—		5
	$	15,540	$	5	$	—	$	15,545

Liabilities:
Interest rate swap	$	—	$	471	$	—	$	471
Foreign currency contracts – acquisition-related		—		14,986		—		14,986
Foreign currency contracts – primarily related to customer sales contracts		—		371		—		371
Liability for contingent payments		—		—		4,359		4,359
	$	—	$	15,828	$	4,359	$	20,187

There were no transfers in or out of Level One, Two or Three during the nine months ended September 28, 2012.

COLFAX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(Unaudited)

Cash Equivalents

The Company’s cash equivalents consist of investments in interest-bearing deposit accounts and money market mutual funds which are valued based on quoted market prices. The fair value of these investments approximates cost due to their short-term maturities and the high credit quality of the issuers of the underlying securities.

Derivatives

The Company periodically enters into foreign currency, interest rate swap, and commodity derivative contracts. The Company uses interest rate swaps to manage exposure to interest rate fluctuations. Foreign currency contracts are used to manage exchange rate fluctuations. Commodity futures contracts are used to manage costs of raw materials used in the Company’s production processes.

The Company enters into such contracts with financial institutions of good standing, and the total credit exposure related to non-performance by those institutions is not material to the operations of the Company. The Company does not enter into derivative contracts for trading purposes.

Interest rate swaps are valued based on forward curves observable in the market. Foreign currency contracts are measured using broker quotations or observable market transactions in either listed or over-the-counter markets. There were no changes during the periods presented in the Company’s valuation techniques used to measure asset and liability fair values on a recurring basis. For transactions in which the instrument has been designated as a cash flow hedge, changes in the fair value of the derivative are reported in Accumulated other comprehensive loss to the extent they are effective at offsetting changes in the hedged item. For transactions in which the instrument has been designated as a fair value hedge, changes in the fair value of the derivative are reported in either Trade receivables or Accounts payable to the extent they are effective at offsetting changes in the hedged item. Changes in the fair value of certain derivatives not designated as hedges, related to the Charter Acquisition, are recognized in Charter acquisition-related expense in the Condensed Consolidated Statements of Operations, while changes in the fair value of all other derivatives not designated as hedges are recognized as a component of Selling, general and administrative expense in the Condensed Consolidated Statements of Operations.

Interest Rate Swap. The notional value of the Company’s interest rate swap was $25 million as of December 31, 2011, which exchanged its LIBOR-based variable-rate interest for a fixed rate of 4.1375%. On January 11, 2012, the Company terminated its interest rate swap in conjunction with the repayment of the Bank of America Credit Agreement and reclassified $0.5 million of net losses from Accumulated other comprehensive loss to Interest expense in the Condensed Consolidated Statement of Operations.

Foreign Currency Contracts. As of September 28, 2012 and December 31, 2011, the Company had foreign currency contracts with the following notional values:

	September 28, 2012		December 31, 2011
	(In thousands)
Foreign currency contracts sold – not designated as hedges	$	261,794	$	—
Foreign currency contracts sold – designated as hedges		243,117		5,116
Foreign currency contracts purchased – not designated as hedges		109,300		—
Foreign currency contracts purchased – designated as hedges		34,089		—
Foreign currency contracts – acquisition related		—		2,749,000
Total foreign currency derivatives	$	648,300	$	2,754,116

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

The Company recognized the following in its Condensed Consolidated Financial Statements related to its derivative instruments:

	Three Months Ended						Nine Months Ended
	September 28, 2012			September 30, 2011			September 28, 2012			September 30, 2011
	(In thousands)
Contracts Designated as Hedges:
Interest Rate Swap:
Unrealized loss	$	—		$	(13	)	$	—		$	(146	)
Realized loss		—			(251	)		(471	)		(1,231	)
Foreign Currency Contracts – related to customer sales contracts:
Unrealized gain		3,070			—			822			—
Realized gain		1,757			—			1,077			—
Foreign Currency Contracts – related to supplier purchase contracts:
Unrealized gain (loss)		497			—			(352	)		—
Realized loss		(579	)		—			(344	)		—
Unrealized loss on net investment hedge		(2,760	)		—			(2,764	)		—
Contracts Not Designated in a Hedge Relationship:
Foreign Currency Contracts – acquisition-related:
Unrealized loss		—			(684	)		—			(684	)
Realized loss		—			—			(7,177	)		—
Foreign Currency Contracts – primarily related to customer sales contracts:
Unrealized gain (loss)		1,551			36			157			210
Realized gain (loss)		880			(545	)		1,756			155

Liability for Contingent Payments

The Company’s liability for contingent payments represents the fair value of estimated additional cash payments related to its acquisition of COT-Puritech in December of 2011, which are subject to the achievement of certain performance goals, and is included in Other liabilities in the Condensed Consolidated Balance Sheets. The fair value of the liability for contingent payments represents the present value of probability weighted expected cash flows based upon the Company’s internal model and projections and is included in Level Three of the fair value hierarchy. During the three and nine months ended September 28, 2012, $0.1 million and $0.5 million of accretion was recognized in Interest expense in the Condensed Consolidated Statements of Operations related to the Company’s liability for contingent payments. Realized or unrealized gains or losses in future periods will be recognized in Selling, general and administrative expense in the Condensed Consolidated Statements of Operations.

15. Commitments and Contingencies

For further description of the Company’s litigation and contingencies, reference is made to Note 17, “Commitments and Contingencies” in the Notes to Consolidated Financial Statements for the year ended December 31, 2011.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

Asbestos and Other Product Liability Contingencies

Claims activity since December 31 related to asbestos claims of our fluid-handling subsidiaries is as follows⁽¹⁾:

	Nine Months Ended
	September 28,			September 30,
	2012			2011
	(Number of claims)
Claims unresolved, beginning of period		23,682			24,764
Claims filed⁽²⁾		2,943			2,799
Claims resolved⁽³⁾		(4,264	)		(5,051	)
Claims unresolved, end of period		22,361			22,512

__________

⁽¹⁾

Excludes claims filed by one legal firm that have been “administratively dismissed.”

⁽²⁾

Claims filed include all asbestos claims for which notification has been received or a file has been opened.

⁽³⁾

Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.

The Company’s Condensed Consolidated Balance Sheets included the following amounts related to asbestos-related litigation:

	September 28, 2012		December 31, 2011
	(In thousands)
Current asbestos insurance asset⁽¹⁾	$	40,726	$	43,452
Current asbestos insurance receivable⁽¹⁾		22,982		33,696
Long-term asbestos insurance asset⁽²⁾		313,623		326,838
Long-term asbestos insurance receivable⁽²⁾		36,111		14,034
Accrued asbestos liability⁽³⁾		68,471		76,295
Long-term asbestos liability⁽⁴⁾		371,139		382,394

__________

⁽¹⁾

Included in Other current assets in the Condensed Consolidated Balance Sheets.

⁽²⁾

Included in Other assets in the Condensed Consolidated Balance Sheets.

⁽³⁾

Represents current reserves for probable and reasonably estimable asbestos-related liability cost that the Company believes the fluid-handling subsidiaries will pay through the next 15 years, overpayments by certain insurers and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Condensed Consolidated Balance Sheets.

⁽⁴⁾

Included in Other liabilities in the Condensed Consolidated Balance Sheets.

In addition to the asbestos litigation of our fluid-handling subsidiaries, certain subsidiaries acquired in conjunction with the Charter Acquisition have been named as defendants in asbestos related actions in the U.S. These lawsuits have alleged that the defendants were liable for acts of a former affiliate. The defendants have contested these actions and, in most cases, have obtained dismissals. The Company expects to continue to defend successfully the actions brought against them.

Additionally, another subsidiary acquired in conjunction with the Charter Acquisition has been named as a defendant in a number of lawsuits in state and federal courts in the U.S. alleging personal injuries from exposure to manganese in the fumes of welding consumables. This subsidiary, along with other co-defendants, entered into an agreement with plaintiffs’ counsel that provides for the dismissal with prejudice of substantially all of the pending manganese claims.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

Management’s analyses are based on currently known facts and a number of assumptions. However, projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded which could materially affect the Company’s financial condition, results of operations or cash flow.

In June 2012, one of the Company’s subsidiaries entered into a settlement agreement for and made a payment of $8.5 million associated with a complaint in a case brought by Litton Industries, Inc. in the Superior Court of New Jersey. The settlement had no impact on the Condensed Consolidated Statements of Operations for the three and nine months ended September 28, 2012.

The Company is also involved in various other pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings are expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings and the litigation and claims described in the preceding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate reserves to cover potential liabilities. Any costs that management estimates may be paid related to these proceedings or claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adverse to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company.

16. Segment Information

Upon the closing of the Charter Acquisition, the Company changed the composition of its reportable segments to reflect the changes in its internal organization resulting from the integration of the acquired businesses. The Company now reports its operations through the following reportable segments:

Gas & Fluid Handling – a global supplier of a broad range of gas- and fluid-handling products, including pumps, fluid-handling systems and controls, specialty valves, heavy-duty centrifugal and axial fans, rotary heat exchangers and gas compressors, which serves customers in the power generation, oil, gas and petrochemical, mining, marine (including defense) and general industrial and other end markets; and

Fabrication Technology – a global supplier of welding equipment and consumables, cutting equipment and consumables and automated welding and cutting systems.

Certain amounts not allocated to the two reportable segments and intersegment eliminations are reported under the heading “Corporate and other.” The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and segment operating income (loss), which represents Operating income before Restructuring and other related charges.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

The Company’s segment results were as follows:

	Three Months Ended						Nine Months Ended
	September 28, 2012			September 30, 2011			September 28, 2012			September 30, 2011
	(In thousands)
Net Sales:
Gas and fluid handling	$	464,873		$	170,294		$	1,386,699		$	515,601
Fabrication technology		489,567			—			1,499,760			—
	$	954,440		$	170,294		$	2,886,459		$	515,601

*Segment operating income (loss)⁽¹⁾:*
Gas and fluid handling	$	33,925		$	20,770		$	98,846		$	61,330
Fabrication technology		43,855			—			106,262			—
Corporate and other		(10,249	)		(10,031	)		(74,201	)		(20,333	)
	$	67,531		$	10,739		$	130,907		$	40,997

Depreciation and Amortization:
Gas and fluid handling	$	27,207		$	5,373		$	84,571		$	17,448
Fabrication technology		14,764			—			53,532			—
Corporate and other		4,280			233			13,175			718
	$	46,251		$	5,606		$	151,278		$	18,166

Capital Expenditures:
Gas and fluid handling	$	10,177		$	4,336		$	29,737		$	10,371
Fabrication technology		7,446			—			28,898			—
Corporate and other		—			4			—			346
	$	17,623		$	4,340		$	58,635		$	10,717

________

⁽¹⁾

The following is a reconciliation of Income before income taxes to segment operating income:

	Three Months Ended				Nine Months Ended
	September 28, 2012		September 30, 2011		September 28, 2012		September 30, 2011
	(In thousands)
Income before income taxes	$	28,109	$	4,222	$	19,561	$	28,972
Interest expense		23,557		1,218		68,280		4,507
Restructuring and other related charges		15,865		5,299		43,066		7,518
Segment operating income	$	67,531	$	10,739	$	130,907	$	40,997

	September 28,		December 31,
	2012		2011
	(In thousands)
Investment in Equity Method Investees:
Gas and fluid handling	$	10,419	$	7,680
Fabrication technology		38,493		—
Corporate and other		—		—
	$	48,912	$	7,680
Total Assets:
Gas and fluid handling	$	3,322,547	$	947,773
Fabrication technology		2,367,526		—
Corporate and other		365,651		140,770
	$	6,055,724	$	1,088,543

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

The detail of the Company’s operations by geography and product type is as follows:

	Three Months Ended				Nine Months Ended
	September 28, 2012		September 30, 2011		September 28, 2012		September 30, 2011
	(In thousands)
Net Sales by Origin:
United States	$	177,802	$	51,824	$	546,614	$	149,467
Foreign		776,638		118,470		2,339,845		366,134
	$	954,440	$	170,294	$	2,886,459	$	515,601
Net Sales by Major Product Group:
Gas handling	$	311,919	$	—	$	898,081	$	—
Fluid handling		152,954		170,294		488,618		515,601
Welding and cutting		489,567		—		1,499,760		—
	$	954,440	$	170,294	$	2,886,459	$	515,601

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of the financial condition and results of operations of Colfax Corporation (“Colfax,” “the Company,” “we,” “our,” and “us”) should be read in conjunction with the Condensed Consolidated Financial Statements and related footnotes included in Part I. Item 1. “Financial Statements” of this Quarterly Report on Form 10-Q for the quarterly period ended September 28, 2012 (this “Form 10-Q”) and the Consolidated Financial Statements and related footnotes included Part II. Item 8. “Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year ended December 31, 2011 (the “2011 Form 10-K”) filed with the Securities and Exchange Commission (the “SEC”) on February 23, 2012.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Some of the statements contained in this Form 10-Q that are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date this Form 10-Q is filed with the SEC. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including statements regarding: projections of revenue, profit margins, expenses, tax provisions and tax rates, earnings or losses from operations, impact of foreign exchange rates, cash flows, pension and benefit obligations and funding requirements, synergies or other financial items; plans, strategies and objectives of management for future operations including statements relating to potential acquisitions, compensation plans or purchase commitments; developments, performance or industry or market rankings relating to products or services; future economic conditions or performance; the outcome of outstanding claims or legal proceedings including asbestos-related liabilities and insurance coverage litigation; potential gains and recoveries of costs; assumptions underlying any of the foregoing; and any other statements that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Further, the forward-looking statements contained herein include statements about the expected effects of the integration of Charter International plc (“Charter”) by Colfax (the “Charter Integration”), the expected benefits from integrating Charter and other benefits associated with the Charter Integration, strategic options and all other statements contained herein regarding the Charter Integration other than historical facts. Forward-looking statements may be characterized by terminology such as “believe,” “anticipate,” “should,” “would,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy,” “targets,” “aims,” “seeks,” “sees,” and similar expressions. These statements are based on assumptions and assessments made by our management in light of their experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. These forward-looking statements are subject to a number of risks and uncertainties, including but not limited to the following:

•

risks related to the Charter Integration including, but not limited to:

•

risks related to any unforeseen liabilities of Charter;

•

our ability to deliver the expected returns and accretive effects on our earnings within our expected timeframes for such returns, or at all;

•

our ability to successfully integrate Charter;

•

our additional leverage as a result of the Charter Acquisition, which may limit our flexibility in operating our business;

•

covenants made to equity investors in connection with the Charter Acquisition that may limit our flexibility in operating our business; and

•

increased exposure to foreign currency risk;

•

risks associated with our international operations;

•

significant movements in foreign currency exchange rates;

•

changes in the general economy, as well as the cyclical nature of our markets;

•

our ability to accurately estimate the cost of or realize savings from our restructuring programs;

•

availability and cost of raw materials, parts and components used in our products;

•

the competitive environment in our industry;

•

our ability to identify, finance, acquire and successfully integrate attractive acquisition targets;

•

the amount of and our ability to estimate our asbestos-related liabilities;

•

material disruption at any of our significant manufacturing facilities;

•

the solvency of our insurers and the likelihood of their payment for asbestos-related costs;

•

our ability to manage and grow our business and execution of our business and growth strategies;

•

our recent substantial leadership turnover and realignment;

•

our ability and the ability of customers to access required capital at a reasonable cost;

•

our ability to expand our business in our targeted markets;

•

our ability to cross-sell our product portfolio to existing customers;

•

the level of capital investment and expenditures by our customers in our strategic markets;

•

our financial performance;

•

our ability to identify, address and remediate any material weaknesses in our internal control over financial reporting;

•

our ability to achieve or maintain credit ratings and the impact on our funding costs and competitive position if we do not do so; and

•

other risks and factors, listed in Item 1A. “Risk Factors” in Part I of our 2011 Form 10-K.

Any such forward-looking statements are not guarantees of future performance and actual results, developments and business decisions may differ materially from those envisaged by such forward-looking statements. These forward-looking statements speak only as of the date this Form 10-Q is filed with the SEC. We do not assume any obligation and do not intend to update any forward-looking statement except as required by law. See Part I. Item 1A. “Risk Factors” in our 2011 Form 10-K for a further discussion regarding some of the reasons that actual results may be materially different from those that we anticipate.

Overview

During the first quarter of 2012, Colfax completed the acquisition of Charter (the “Charter Acquisition”) which has transformed Colfax from a fluid-handling organization into a multi-platform enterprise with a strong global footprint. Following the Charter Acquisition, Colfax reports its operations through the following reportable segments:

Fabrication Technology – a global supplier of welding equipment and consumables, cutting equipment and consumables and automated welding and cutting systems.

Colfax has a global geographic footprint, with production facilities in Europe, North America, South America, Asia, Australia and Africa. Through our operating segments, we serve a global customer base across multiple markets through a combination of direct sales and third-party distribution channels. Our customer base is highly diversified and includes commercial, industrial and government customers.

We employ a comprehensive set of tools that we refer to as the Colfax Business System (“CBS”). CBS is a disciplined strategic planning and execution methodology designed to achieve excellence and world-class financial performance in all aspects of our business by focusing on the Voice of the Customer and continuously improving quality, delivery and cost. Modeled on the Danaher Business System, CBS focuses on conducting root-cause analysis, developing process improvements and implementing sustainable systems. Our approach addresses the entire business, not just manufacturing operations.

Outlook

We believe that we are well positioned to grow our businesses organically over the long term by enhancing our product offerings and expanding our customer base. Subsequent to the Charter Acquisition in the first quarter of 2012, our business mix is expected to be well balanced between long- and short-cycle businesses, sales in emerging markets and developed nations and fore- and aftermarket products and services. Given this balance, management no longer uses indices other than general economic trends to predict the overall outlook for the Company. Instead, the individual businesses monitor key competitors and customers, including to the extent possible their sales, to gauge relative performance and outlook for the future.

We expect that the stronger U.S. dollar against most foreign currencies, compared to 2011, is likely to reduce reported sales and operating profits proportionately during the remainder of 2012. In addition, we believe that the recent weakness in the economic outlook for Europe, China and Brazil is likely to impact near term results.

As a result of the Charter Acquisition, we face a number of challenges and opportunities, including the successful integration, application and expansion of our CBS tools to improve margins and working capital management, rationalization of assets and back office functions, and consolidation of manufacturing facilities.

We expect to continue to grow as a result of strategic acquisitions. We believe that the extensive experience of our leadership team in acquiring and effectively integrating acquisition targets should enable us to capitalize on opportunities in the future.

Results of Operations

Upon the closing of the Charter Acquisition, we changed the composition of our reportable segments to reflect the changes in our internal organization resulting from the integration of the acquired businesses. The Company now reports its operations through two reportable segments: gas and fluid handling and fabrication technology. Certain amounts not allocated to the two reportable segments and intersegment eliminations are reported under the heading “Corporate and other.” The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and segment operating income (loss), which represents Operating income before Restructuring and other related charges.

Items Affecting Comparability of Reported Results

In addition to the impact of the Charter Acquisition and the change in composition of our reportable segments, the comparability of our operating results for the third quarter and nine months ended September 28, 2012 to the respective 2011 period is affected by the following additional significant items:

Strategic Acquisitions

We complement our organic growth with strategic acquisitions. Acquisitions can significantly affect our reported results and can complicate period to period comparisons of results. As a consequence, we report the change in our Net sales between periods both from existing and acquired businesses. Orders and order backlog are presented only for the gas- and fluid-handling segment, where this information is relevant. The discussion of Net sales, orders and order backlog in comparison to the respective 2011 period is a proforma comparison that includes the operations acquired in the Charter Acquisition for the comparable period of the prior year, which excludes the first 12 days of 2011. The change in Net sales due to acquisitions represents the change in sales due to the following acquisitions by both Colfax and Charter:

On September 13, 2012, Colfax completed the acquisition of the Co-Vent Group Inc. (“Co-Vent”) for $32.3 million. Co-Vent specializes in the custom design, manufacture, and testing of industrial fans, with its primary operations based in Quebec, Canada. As a result of this acquisition, Colfax has expanded its product offerings in the industrial fan market.

In May 2012, Colfax acquired the remaining 83.7% of CJSC Sibes (“Sibes”) not already owned by its ESAB business for approximately $8.5 million, including the assumption of debt. Sibes is a leading supplier of welding electrodes to customers in Eastern Russia and strengthens ESAB’s position in the attractive Russian welding consumables market, particularly in the energy and natural resources end markets.

On December 6, 2011, Colfax completed the acquisition of COT-Puritech, Inc. for a total purchase price, net of cash acquired, of $39.4 million which includes the fair value of estimated additional contingent cash payments of $4.3 million. The additional contingent cash payments will be paid over two years subject to the achievement of certain performance goals. COT-Puritech, Inc. is a national supplier of oil flushing and remediation services to power generation plants, refinery and petrochemical operations and other manufacturing sites, with its primary operations based in Canton, Ohio.

On July 1, 2011, ESAB acquired 60% of Condor Equipamentos Industriais Ltda (“Condor”), a leading Brazilian manufacturer of gas apparatus used in welding applications, for cash consideration of R$25.2 million.

On March 28, 2011, Howden completed the acquisition of Thomassen Compression Systems BV (“Thomassen”), a leading supplier of high-powered engineered compressors to the oil, gas and petrochemical end market, for approximately €100 million.

On March 3, 2011, ESAB completed the acquisition of LLC Sychevsky Electrodny Zavod (“Sychevsky”), a leading Russian electrode manufacturer based in the Smolensk region for $19.2 million.

On February 14, 2011, Colfax completed the acquisition of Rosscor for $22.3 million, net of cash acquired. Rosscor is a supplier of multiphase pumping technology and certain other highly engineered fluid-handling systems, with its primary operations based in Hengelo, The Netherlands.

Foreign Currency Fluctuations

A significant portion of our Net sales, approximately 81% for both the three and nine months ended September 28, 2012 is derived from operations outside the U.S., with the majority of those sales denominated in currencies other than the U.S. dollar. Because much of our manufacturing and employee costs are outside the U.S., a significant portion of our costs are also denominated in currencies other than the U.S. dollar. Changes in foreign exchange rates can impact our results of operations and are quantified when significant to our discussion.

Seasonality

The results of operations for the three and nine months ended September 28, 2012 are not necessarily indicative of the results of operations that may be achieved for the full year. Quarterly results are affected by seasonal variations in the Company’s gas- and fluid-handling segment. As the Company’s customers seek to fully utilize capital spending budgets before the end of the year, historically shipments have peaked during the fourth quarter. General economic conditions as well as backlog levels may, however, impact future seasonal variations.

Sales, Orders and Backlog

Our consolidated Net sales decreased by $17.3 million in the third quarter of 2012 in comparison to the proforma net sales for the third quarter of 2011. For the nine months ended September 28, 2012, our consolidated Net sales increased from proforma net sales of $2.8 billion in the nine months ended September 30, 2011 to $2.9 billion (which excludes operations acquired in the Charter Acquisition for the first 12 days of each nine month reporting period presented). The following tables present components of our proforma consolidated Net sales and, for our gas- and fluid-handling segment, proforma order and backlog growth:

	Net Sales						Orders⁽¹⁾
	$			%			$			%
	(In millions)
Proforma for the three months ended September 30, 2011	$	971.7					$	451.2
Components of Change:
Existing businesses⁽²⁾		49.5			5.1	%		18.0			4.0	%
Acquisitions⁽³⁾		5.3			0.5	%		4.2			0.9	%
Foreign currency translation⁽⁴⁾		(72.1	)		(7.4	)%		(29.6	)		(6.5	)%
		(17.3	)		(1.8	)%		(7.4	)		(1.6	)%
Three months ended September 28, 2012	$	954.4					$	443.8

	Net Sales						Orders⁽¹⁾						Backlog at Period End
	$			%			$			%			$			%
	(In millions)
Proforma as of and for the nine months ended September 30, 2011	$	2,789.3					$	1,425.6					$	1,348.2
Components of Change:
Existing businesses⁽²⁾		228.7			8.2	%		44.4			3.1	%		70.0			5.2	%
Acquisitions⁽³⁾		52.3			1.9	%		78.3			5.5	%		12.2			0.9	%
Foreign currency translation⁽⁴⁾		(183.8	)		(6.6	)%		(72.6	)		(5.1	)%		(51.3	)		(3.8	)%
		97.2			3.5	%		50.1			3.5	%		30.9			2.3	%
As of and for the nine months ended September 28, 2012	$	2,886.5					$	1,475.7					$	1,379.1

__________

⁽¹⁾

Represents contracts for products or services, net of cancellations for the period for our gas- and fluid-handling operating segment.

⁽²⁾

Excludes the impact of foreign exchange rate fluctuations and acquisitions, thus providing a measure of growth due to factors such as price, product mix and volume.

⁽³⁾

Represents the incremental sales, orders and order backlog as a result of our acquisitions of Co-Vent, Sibes, COT-Puritech and Rosscor and the acquisition of Thomassen by Howden and Sychevsky and Condor by ESAB.

⁽⁴⁾

Represents the difference between sales from existing businesses valued at current year foreign exchange rates and sales from existing businesses at prior year foreign exchange rates.

The proforma increase in Net sales from existing businesses in the third quarter of 2012 was attributable to an increase of $61.6 million in our gas- and fluid-handling segment, partially offset by a $12.1 million decrease in our fabrication technology segment. Orders, net of cancellations, from existing businesses for our gas- and fluid-handling segment increased during the third quarter of 2012 in comparison to the third quarter of 2011 primarily due to growth in the power generation, mining and general industrial and other end markets.

The proforma increase in Net sales from existing businesses in the nine months ended September 28, 2012 was attributable to increases of $176.6 million and $52.1 million in our gas- and fluid-handling and fabrication technology segments, respectively. Orders, net of cancellations, from existing businesses for our gas- and fluid-handling segment increased during the nine months ended September 28, 2012 in comparison to the comparable 2011 period primarily due to growth in the power generation end market.

Segments

As discussed further above, the Company now reports results in two reportable segments: gas and fluid handling and fabrication technology. The following table summarizes Net sales by business segment for each of the following periods:

	Three Months Ended				Nine Months Ended
	September 28, 2012		Proforma September 30, 2011		September 28, 2012		Proforma September 30, 2011
	(In millions)
Gas and Fluid Handling	$	464.9	$	422.9	$	1,386.7	$	1,226.8
Fabrication Technology		489.5		548.8		1,499.8		1,562.5
Total Net sales	$	954.4	$	971.7	$	2,886.5	$	2,789.3

The sales comparisons discussed above are on a proforma basis. Cost information for Charter, ESAB and Howden is not available under the presentation required by the Exchange Act and, as such, proforma discussions are limited to sales.

Gas and Fluid Handling

We design, manufacture, install and maintain gas- and fluid-handling products for use in a wide range of markets, including power generation, oil, gas and petrochemical, mining, marine (including defense) and general industrial and other. Our gas-handling products are principally marketed under the Howden brand name. Howden’s primary products are heavy-duty fans, rotary heat exchangers and compressors. The fans and heat exchangers are used in coal-fired and other types of power stations, both in combustion and emissions control applications, underground mines, steel sintering plants and other industrial facilities that require movement of large volumes of air in harsh applications. Howden’s compressors are mainly used in the oil, gas and petrochemical end market. Our fluid-handling products are marketed by Colfax Fluid Handling under a portfolio of brands including Allweiler, Baric, Fairmount Automation, Houttuin, Imo, LSC, COT-Puritech, Portland Valve, Tushaco, Warren and Zenith. Colfax Fluid Handling is a supplier of a broad range of fluid-handling products, including pumps, fluid-handling systems and controls, and specialty valves.

The following table summarizes the selected financial data for our gas- and fluid-handling segment:

	Three Months Ended						Nine Months Ended
	September 28, 2012			September 30, 2011			September 28, 2012			September 30, 2011
	(Dollars in millions)
Net sales	$	464.9		$	170.3		$	1,386.7		$	515.6
Gross profit		139.0			60.6			410.7			178.6
Gross profit margin		29.9	%		35.6	%		29.6	%		34.6	%
Restructuring and other related charges	$	1.6		$	5.3		$	5.4		$	6.5
Selling, general and administrative expense		101.8			41.1			303.0			123.4
Selling, general and administrative expense as a percentage of Net sales		21.9	%		24.1	%		21.9	%		23.9	%
Segment operating income	$	33.9		$	20.8		$	98.8		$	61.3
Segment operating income margin		7.3	%		12.2	%		7.1	%		11.9	%

Year over year fluctuations for the selected financial data are primarily due to the addition of the Howden operations. The $61.6 million sales growth due to existing businesses, as discussed and defined under “Sales, Orders and Backlog” above, during the third quarter of 2012 in comparison to the third quarter of 2011 was primarily due to growth in all end markets, except marine. Additionally, $14.5 million of acquisition-related amortization expense and $3.6 million increased recurring intangible amortization expense in comparison to the third quarter of 2011 is reflected in Selling, general and administrative expense for the third quarter of 2012.

The $176.6 million sales growth due to existing businesses, as discussed and defined under “Sales, Orders and Backlog” above, during the nine months ended September 28, 2012 in comparison to the nine months ended September 30, 2011 was primarily due to growth in all end markets, except marine. Additionally, $4.5 million and $41.1 million of acquisition-related amortization expense is reflected in Gross profit and Selling, general and administrative expense, respectively, for the nine months ended September 28, 2012, and recurring intangible amortization expense included in Selling, general and administrative expense increased by $9.4 million in comparison to the nine months ended September 30, 2011.

Fabrication Technology

We formulate, develop, manufacture and supply consumable products and equipment for use in the cutting and joining of steels, aluminum and other metals and metal alloys. Our fabrication technology products are principally marketed under the ESAB brand name, which we believe is a leading international welding company with roots dating back to the invention of the welding electrode. ESAB’s comprehensive range of welding consumables includes electrodes, cored and solid wires and fluxes. ESAB’s fabrication technology equipment ranges from portable units to large custom systems. Products are sold into a wide range of end markets, including wind power, shipbuilding, pipelines, mobile/off-highway equipment and mining.

The following table summarizes the selected financial data for our fabrication technology segment:

	Three Months Ended September 28,			Nine Months Ended September 28,
	2012			2012
	(Dollars in millions)
Net sales	$	489.5		$	1,499.8
Gross profit		149.0			433.8
Gross profit margin		30.4	%		28.9	%
Restructuring and other related charges	$	12.5		$	31.6
Selling, general and administrative expense		105.1			327.6
Selling, general and administrative expense as a percentage of Net sales		21.5	%		21.8	%
Segment operating income	$	43.9		$	106.3
Segment operating income margin		9.0	%		7.1	%

The $12.1 million sales decline due to existing businesses, as discussed and defined under “Sales, Orders and Backlog” above, during the third quarter of 2012 in comparison to the third quarter of 2011 reflects a globally broad-based decline in consumable volumes due to the deteriorating global economic conditions. The $52.1 million sales growth due to existing businesses during the nine months ended September 28, 2012 in comparison to the comparable 2011 period was primarily due to increased consumable and equipment sales in North America and the Middle East. Year over year comparison of the other selected financial data above is not practical, as further discussed above. Additionally, Gross profit and gross profit margin for the nine months ended September 28, 2012 were impacted by acquisition-related amortization and inventory step-up expense of $17.0 million. There was no acquisition-related amortization and inventory step-up expense during the third quarter of 2012.

Gross Profit – Total Company

	Three Months Ended						Nine Months Ended
	September 28, 2012			September 30, 2011			September 28, 2012			September 30, 2011
		(Dollars in millions)
Gross profit	$	288.0		$	60.7		$	844.6		$	178.6
Gross profit margin		30.2	%		35.6	%		29.3	%		34.6	%

The $227.3 million increase in Gross profit during the third quarter of 2012 in comparison to the third quarter of 2011 was attributable to increases of $78.4 million in our gas- and fluid-handling segment and $149.0 million in our fabrication technology segment. Additionally, changes in foreign exchange rates had a $22.3 million negative impact on Gross profit in comparison to the third quarter of 2011. The $666.0 million increase in Gross profit during the nine months ended September 28, 2012 in comparison to the nine months ended September 30, 2011 was attributable to increases of $232.1 million in our gas- and fluid-handling segment and $433.8 million in our fabrication technology segment. Additionally, changes in foreign exchange rates had a $58.2 million negative impact on Gross profit in comparison to the nine months ended September 30, 2011.

Gross profit margin for the third quarter and nine months ended September 28, 2012 decreased compared to the comparable 2011 period primarily due to the lower gross profit margin associated with sales in our fabrication technology segment during the period. Additionally, Gross profit and gross profit margin for the nine months ended September 28, 2012 were impacted by acquisition-related amortization expense of $21.5 million. There was no acquisition-related amortization and inventory step-up expense during the third quarter of 2012.

Operating Expenses – Total Company

	Three Months Ended						Nine Months Ended
	September 28, 2012			September 30, 2011			September 28, 2012			September 30, 2011
	(Dollars in millions)
Selling, general and administrative expense	$	217.1		$	41.1		$	661.2		$	123.4
Selling, general and administrative expense as a percentage of Net sales		22.8	%		24.1	%		22.9	%		23.9	%
Charter acquisition-related expense	$	—		$	5.7		$	43.6		$	5.7
Restructuring and other related charges		15.9			5.3			43.1			7.5
Asbestos coverage litigation expense		3.3			3.1			8.8			8.5

Selling, general and administrative expense increased $176.0 million during the third quarter in comparison to the third quarter of 2011 primarily due to the Charter Acquisition. The decrease in Selling, general and administrative expense as a percentage of Net sales during the third quarter of 2012 in comparison to the comparable prior year period resulted primarily from the benefit of higher sales volumes and efforts to reduce costs, partially offset by $19.5 million of higher intangible amortization expense.

Selling, general and administrative expense increased $537.8 million during the nine months ended September 28, 2012 in comparison to the comparable period of 2011 primarily due to the Charter Acquisition. The decrease in Selling, general and administrative expense as a percentage of Net sales during the nine months ended September 28, 2012 in comparison to the comparable prior year period resulted primarily from the benefit of higher sales volumes and efforts to reduce costs partially offset by $55.5 million of higher intangible amortization expense. During the nine months ended September 28, 2012, we incurred $37.9 million of increased advisory, legal, valuation and other professional service fees and losses on acquisition-related foreign exchange derivatives in connection with the Charter Acquisition in comparison to the nine months ended September 30, 2011.

Selling, general and administrative expenses for the third quarter and nine months ended September 30, 2011 include a $2.1 million provision related to a court judgment received for one of our subsidiaries’ litigation against a number of its insurers and former parent.

Restructuring and other related charges increased significantly during 2012 in comparison to the comparable periods of 2011, primarily as a result of the substantial cost reduction programs under way in the fabrication technology segment.

Interest Expense – Total Company

	Three Months Ended				Nine Months Ended
	September 28, 2012		September 30, 2011		September 28, 2012		September 30, 2011
	(In millions)
Interest expense	$	23.6	$	1.2	$	68.3	$	4.5

The increase in Interest expense during the third quarter and nine months ended September 28, 2012 in comparison to the respective period in 2011 was attributable to interest on the financing related to the Charter Acquisition. See “—Liquidity and Capital Resources—Borrowing Arrangements” below for additional discussion.

Provision for Income Taxes – Total Company

The effective income tax rate for the third quarter of 2012 was 48.4% compared to an effective income tax rate of 12.6% during the third quarter of 2011. Our effective income tax rate for the third quarter of 2012 was significantly impacted by corporate overhead and Interest expense related to the combined organization, which was incurred in jurisdictions where no tax benefit can be recognized. These items were partially offset by a discrete credit to income tax expense of $2.9 million from a reduction to deferred tax balances in the United Kingdom associated with the enactment of lower corporate tax rates. Our effective income tax rate for the third quarter of 2011 was lower than the U.S. federal statutory rate primarily due to the cumulative effect of a change in the estimated annual tax rate due to the impact of changes in the anticipated pretax income for 2011 in the various jurisdictions we operate in.

During the nine months ended September 28, 2012, Income before income taxes was $19.6 million and the Provision for income taxes was $86.9 million. The provision was impacted by two significant items. Upon completion of the Charter Acquisition, certain deferred tax assets existing at that date were reassessed in light of the impact of the acquired businesses on expected future income or loss by country and future tax planning, including the impact of the post-acquisition capital structure. This assessment resulted in an increase in our valuation allowance to provide full valuation allowances against U.S. deferred tax assets. The increased valuation allowances resulted in a non-cash increase in the Provision for income taxes for the nine months ended September 28, 2012 of $50.3 million. In addition, $43.6 million of Charter acquisition-related expense and increased corporate overhead and Interest expense reflected in the Condensed Consolidated Statement of Operations are either non-deductible or were incurred in jurisdictions where no tax benefit can be recognized. These two items are the principal cause of the Provision for income taxes being significantly higher than the tax provision which would result from the application of the U.S. federal statutory rate.

The effective income tax for the nine months ended September 30, 2011 was 28.8%, which was lower than the U.S. federal statutory rate primarily due to foreign earnings where international tax rates are lower than the U.S. tax rate and the impact of the change in the estimated annual tax rate, discussed above.

Liquidity and Capital Resources

Overview

Historically, we have financed our capital and working capital requirements through a combination of cash flows from operating activities and borrowings under our bank credit facilities (discussed below). Additionally, during the first quarter of 2012, we were successful in our efforts to raise additional funds in the form of debt and equity, as further discussed below. We expect that our primary ongoing requirements for cash will be for working capital, funding of acquisitions, capital expenditures, asbestos-related cash outflows and funding of our pension plans. If additional funds are needed for strategic acquisitions or other corporate purposes, we believe we could raise additional funds in the form of debt or equity.

Equity Capital

In connection with the financing of the Charter Acquisition, on January 24, 2012, we sold to the BDT Investor (i) 14,756,945 shares of newly issued Colfax Common stock and (ii) 13,877,552 shares of newly created Series A perpetual convertible preferred stock, referred to as the Series A Preferred Stock, for an aggregate of $680 million (representing $24.50 per share of Series A Preferred Stock and $23.04 per share of Common stock) pursuant to a securities purchase agreement (the “BDT Purchase Agreement”) with the BDT Investor as well as BDT Capital Partners Fund I-A, L.P., and Mitchell P. Rales, Chairman of our Board of Directors, and his brother, Steven M. Rales (for the limited purpose of tag-along sales rights provided to the BDT Investor in the event of a sale or transfer of shares of our Common stock by either or both of Mitchell P. Rales and Steven M. Rales). Pursuant to the BDT Purchase Agreement, under the terms of the Series A Preferred Stock, holders are entitled to receive cumulative cash dividends, payable quarterly, at a per annum rate of 6% of the liquidation preference (defined as $24.50, subject to customary antidilution adjustments), provided that the dividend rate shall be increased to a per annum rate of 8% if Colfax fails to pay the full amount of any dividend required to be paid on such shares until the date that full payment is made.

The Series A Preferred Stock is convertible, in whole or in part, at the option of the holders at any time after the date the shares were issued into shares of Colfax Common stock at a conversion rate determined by dividing the liquidation preference by a number equal to 114% of the liquidation preference, subject to certain adjustments. The Series A Preferred Stock is also convertible, in whole or in part, at our option on or after the third anniversary of the issuance of the shares at the same conversion rate if, among other things: (i) for the preceding thirty trading days, the closing price of Colfax Common stock on the New York Stock Exchange exceeds 133% of the applicable conversion price and (ii) Colfax has declared and paid or set apart for payment all accrued but unpaid dividends on the Series A Preferred Stock.

On January 24, 2012, we sold 2,170,139 shares of newly issued Colfax Common stock to each of Mitchell P. Rales and Steven M. Rales and 1,085,070 shares of newly issued Colfax Common stock to Markel Corporation (“Markel”) at $23.04 per share, for an aggregate of $125 million pursuant to separate securities purchase agreements with Mitchell P. Rales, Chairman of Colfax’s Board of Directors, and his brother Steven M. Rales, each of whom were beneficial owners of 20.9% of Colfax’s Common stock, and Markel. Thomas S. Gayner, a member of Colfax’s Board of Directors, is President and Chief Investment Officer of Markel.

On March 5, 2012, we sold 8,000,000 shares of newly issued Common stock to the underwriters for public resale pursuant to a shelf registration statement for an aggregate purchase price of $272 million. Further, on March 9, 2012, the underwriters of the March 5, 2012 equity offering exercised their over-allotment option and we sold an additional 1,000,000 shares of newly issued Common stock to the underwriters for public resale pursuant to a shelf registration statement for an aggregate purchase price of $34 million. In conjunction with these issuances, we recognized $12.6 million in equity issuance costs which were recorded as a reduction to Additional paid-in capital during the nine months ended September 28, 2012.

Borrowing Arrangements

We entered into the Deutsche Bank Credit Agreement on September 12, 2011. In connection with the closing of the Charter Acquisition, the Deutsche Bank Credit Agreement was amended on January 13, 2012 and we terminated our Bank of America Credit Agreement (defined and further discussed below) as well as Charter’s outstanding indebtedness. The Deutsche Bank Credit Agreement has four tranches of term loans: (i) a $200 million term A-1 facility, (ii) a $500 million term A-2 facility, (iii) a €157.6 million term A-3 facility and (iv) a $900 million term B facility. In addition, the Deutsche Bank Credit Agreement has two revolving credit facilities which total $300 million in commitments (the “Revolver”). The Revolver includes a $200 million letter of credit sub-facility and a $50 million swingline loan sub-facility. The term A-1, term A-2, term A-3 and the Revolver variable-rate borrowings are subject to interest payments of LIBOR or EURIBOR plus a margin ranging from 2.50% to 3.25%, determined by our leverage ratio. Borrowings under the term B facility are also variable rate and are subject to interest payments of LIBOR plus a margin of 3.5%. The Revolver is subject to a commitment fee ranging from 37.5 and 50 basis points, determined by our leverage ratio. Additionally, as of September 28, 2012, there was an original issue discount of $59.3 million and deferred financing fees of $9.3 million, which will be accreted to Interest expense primarily using the effective interest method. As of September 28, 2012, the weighted-average interest rate on outstanding borrowings under the Deutsche Bank Credit Agreement was 3.87% and there was $291.9 million available on the Revolver, including $191.9 million available on the letter of credit sub-facility.

As of December 31, 2011, we were party to a credit agreement (the “Bank of America Credit Agreement”), led and administered by Bank of America, which included a senior secured revolving credit facility and a term credit facility. Upon the early termination of the Bank of America Credit Agreement, we incurred a total pre-tax charge of $1.5 million in the nine months ended September 28, 2012, which includes the write-off of $1.0 million of deferred financing fees and $0.5 million of losses reclassified from Accumulated other comprehensive loss for the related interest rate swap.

In connection with the Deutsche Bank Credit Agreement, we have pledged substantially all of our domestic subsidiaries’ assets and 65% of the shares of certain first tier international subsidiaries as collateral against borrowings to our U.S. companies. In addition, subsidiaries in certain foreign jurisdictions have guaranteed our obligations on borrowings of one of our European subsidiaries, as well as pledged substantially all of their assets for such borrowings of this European subsidiary under the Deutsche Bank Credit Agreement. The Deutsche Bank Credit Agreement contains customary covenants limiting our ability to, among other things, pay dividends, incur debt or liens, redeem or repurchase equity, enter into transactions with affiliates, make investments, merge or consolidate with others or dispose of assets. In addition, the Deutsche Bank Credit Agreement contains financial covenants requiring us to maintain a total leverage ratio, as defined therein, of not more than 4.95 to 1.0 and a minimum interest coverage ratio, as defined therein, of 2.0 to 1.0, measured at the end of each quarter, through 2012. The minimum interest coverage ratio increases by 25 basis points each year beginning in 2013 until it reaches 3.0 to 1.0 for 2016. The maximum total leverage ratio decreases to 4.75 to 1.0 for 2014 and decreases by 25 basis points for the two subsequent fiscal years until it reaches 4.25 to 1.0 for 2016. The Deutsche Bank Credit Agreement contains various events of default, including failure to comply with such financial covenants, and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the term loans and the Revolver and foreclose on the collateral. The Company is in compliance with all such covenants as of September 28, 2012. We believe that our sources of liquidity, including the Deutsche Bank Credit Agreement, are adequate to fund our operations for the next twelve months.

Cash Flows

As of September 28, 2012, we had $517.3 million of Cash and cash equivalents, an increase of $442.2 million from $75.1 million as of December 31, 2011. The following table summarizes the change in Cash and cash equivalents during the periods indicated:

	Nine Months Ended
	September 28,			September 30,
	2012			2011
	(In millions)
Net cash provided by operating activities	$	1.1		$	41.7

Purchases of fixed assets, net		(58.6	)		(10.7	)
Acquisitions, net of cash received		(1,692.0	)		(22.3	)
Net cash used in investing activities		(1,750.6	)		(33.0	)

Proceeds from (repayments of) borrowings, net		1,161.2			(7.5	)
Proceeds from issuance of common stock, net		755.1			—
Proceeds from issuance of preferred stock, net		333.0			—
ESAB India repurchase of additional noncontrolling interest		(29.3	)		—
Other uses, net		(12.4	)		2.2
Net cash provided by (used in) financing activities		2,207.6			(5.3	)

Effect of exchange rates on cash and cash equivalents		(15.9	)		0.5

Increase in cash and cash equivalents	$	442.2		$	3.9

Cash flows from operating activities can fluctuate significantly from period to period due to changes in working capital and the timing of payments for items such as pension funding. Changes in significant operating cash flow items are discussed below.

Net cash received or paid for asbestos-related costs, net of insurance proceeds, including the disposition of claims, defense costs and legal expenses related to litigation against our insurers, creates variability in our operating cash flows. During the nine months ended September 28, 2012, we had net cash outflows of $34.3 million compared to net cash inflows of $1.7 million during the nine months ended September 30, 2011.

Funding requirements of our defined benefit plans, including pension plans and other post-retirement benefit plans, can vary significantly from period to period due to changes in the fair value of plan assets and actuarial assumptions. For the nine months ended September 28, 2012 and September 30, 2011, cash contributions for defined benefit plans were $50.3 million and $6.3 million, respectively. The nine months ended September 28, 2012 included $18.9 million of supplemental contributions to pension plans in the United Kingdom as a result of the financing of the Charter Acquisition.

	Ÿ	During the nine months ended September 28, 2012 and September 30, 2011, cash payments of $32.4 million and $4.5 million, respectively, were made related to our restructuring initiatives. Additionally, during the nine months ended September 28, 2012, cash payments of approximately $45 million were made for advisory, legal, valuation and other professional service fees related to the Charter Acquisition.

Changes in net working capital also affected the operating cash flows for the periods presented. We define working capital as Trade receivables, net and Inventories, net reduced by Accounts payable. During the nine months ended September 28, 2012, net working capital increased, primarily due to an increase in inventory and receivable levels, which reduced our cash flows from operating activities. During the nine months ended September 30, 2011, net working capital increased, primarily due to an increase in inventory levels, which reduced our cash flows from operating activities.

There were significant investing activities associated with the Charter Acquisition. The cash cost of the Charter Acquisition, net of cash acquired, was approximately $1.7 billion. During the nine months ended September 30, 2011, the Rosscor acquisition resulted in net cash outflows of $22.3 million. Capital expenditures for the nine months ended September 28, 2012 of $63.3 million were significantly higher than $10.7 million used in the nine months ended September 30, 2011 due to the much larger scale of our operations in the nine months ended September 28, 2012.

Cash flows from financing activities were also significantly impacted by the Charter Acquisition. As discussed above under “—Equity Capital,” we raised $805.0 million of cash from sales of our equity securities to the BDT Investor, Steven and Mitchell Rales and Markel, and $293 million in a primary offering settled in March 2012. Also, as further discussed above under “—Borrowing Arrangements,” we borrowed approximately $1.8 billion of term loans, $68.0 million of which was repaid in the nine months ended September 28, 2012. The additional payment of borrowings under term loans of $455 million primarily represents the repayment of borrowings under our Bank of America Credit Agreement, in conjunction with the financing of the Charter Acquisition. We also made cash payments for preferred stock dividends of $12.4 million. Net repayments of $7.5 million during the nine months ended September 30, 2011 resulted from the use of cash generated from our operating activities to repay outstanding indebtedness.

Our cash flows from financing activities during the nine months ended September 28, 2012 were also impacted by a $29.4 million acquisition of shares in ESAB India Limited, a publicly traded, less than wholly owned subsidiary in which the Company acquired a controlling interest in the Charter Acquisition. This acquisition of shares was pursuant to a statutorily mandated tender offer triggered as a result of the Charter Acquisition.

See “—Borrowing Arrangements” above for additional information regarding our outstanding indebtedness as of September 28, 2012.

Our Cash and cash equivalents as of September 28, 2012 includes $288.2 million held in jurisdictions outside the U.S., which may be subject to tax penalties and other restrictions if repatriated into the U.S.

Contractual Obligations

Our contractual obligations changed materially from December 31, 2011, primarily as a result of the Charter Acquisition. The following table summarizes our future contractual obligations as of September 28, 2012.

	Less Than One Year		1-3 Years		3-5 Years		More Than 5 Years		Total
	(In millions)
Debt	$	29.4	$	177.7	$	692.4	$	852.9	$	1,752.4
Interest payments on debt⁽¹⁾		67.7		129.7		152.7		49.6		399.7
Operating leases		26.9		33.9		14.7		34.6		110.1
Capital leases		31.3		1.6		0.3		—		33.2
Purchase obligations⁽²⁾		312.7		32.7		0.3		0.1		345.8
Total	$	468.0	$	375.6	$	860.4	$	937.2	$	2,641.2

__________

⁽¹⁾

Variable interest payments are estimated using a static rate of 3.87%.

⁽²⁾

Excludes open purchase orders for goods or services that are provided on demand, the timing of which is not certain.

On May 26, 2012, the Company entered into a share purchase agreement with Inversiones Breca S.A. to acquire an interest of approximately 91% of Soldex S.A. (“Soldex”) for approximately $183.4 million. Soldex is organized under the laws of Peru and supplies welding products from its plants in Colombia and Peru. The acquisition is subject to certain regulatory approvals and is currently expected to close in the fourth quarter of 2012. We expect to fund the acquisition with cash on hand.

We have cash funding requirements associated with our pension and other post-retirement benefit plans as of September 28, 2012, which are estimated to be approximately $5 million to $15 million for the remainder of 2012. Other long-term liabilities, such as those for asbestos and other legal claims, employee benefit plan obligations, and deferred income taxes, are excluded from the above table since they are not contractually fixed as to timing and amount.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that provide liquidity, capital resources, market or credit risk support that expose us to any liability that is not reflected in our Condensed Consolidated Financial Statements other than outstanding letters of credit of $346.8 million, $178.7 million of bank guarantees and $110.1 million of future operating lease payments as of September 28, 2012.

Critical Accounting Policies

The methods, estimates and judgments that we use in applying our critical accounting policies have a significant impact on our results of operations and financial position. We evaluate our estimates and judgments on an ongoing basis. Our estimates are based upon our historical experience, our evaluation of business and macroeconomic trends and information from other outside sources, as appropriate. Our experience and assumptions form the basis for our judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may vary from what our management anticipates and different assumptions or estimates about the future could have a material impact on our results of operations and financial position. Significant additions to the methods, estimates and judgments from those included in Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in our 2011 Form 10-K, resulting from the Charter Acquisition are as follows:

Revenue Recognition – Construction Contracts

We recognize revenue and cost of sales on construction projects using the “percentage of completion method” in accordance with U.S. GAAP. Under this method, contract revenues are recognized over the performance period of the contract in direct proportion to the costs incurred as a percentage of total estimated costs for the entirety of the contract. Any recognized revenues that have not been billed to a customer are recorded as a component of Trade receivables and any billings of customers in excess of recognized revenues are recorded as a component of Accounts payable. As of September 28, 2012, there were $148.3 million of revenues in excess of billings and $170.4 million of billings in excess of revenues on construction contracts in the Condensed Consolidated Balance Sheet.

We have contracts in various stages of completion. Such contracts require estimates to determine the appropriate cost and revenue recognition. Significant management judgments and estimates, including estimated costs to complete projects, must be made and used in connection with revenue recognized during each period. Current estimates may be revised as additional information becomes available. The revisions are recorded in income in the period in which they are determined using the cumulative catch-up method of accounting.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk from changes in short-term interest rates, foreign currency exchange rates and commodity prices that could impact our results of operations and financial condition. We address our exposure to these risks through our normal operating and financing activities.

Interest Rate Risk

We are subject to exposure from changes in short-term interest rates related to interest payments on our borrowing arrangements. Under the Deutsche Bank Credit Agreement, all of our borrowings as of September 28, 2012 are variable-rate facilities based on LIBOR or EURIBOR. In order to mitigate our interest rate risk, we periodically enter into interest rate swap or collar agreements. A hypothetical increase in the interest rate of 1.00% during the third quarter and nine months ended September 28, 2012 would have increased Interest expense by approximately $4.4 million and $13.3 million, respectively.

Exchange Rate Risk

We have manufacturing sites throughout the world and sell our products globally. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. dollar and against the currencies of other countries in which we manufacture and sell products and services. During both the third quarter and nine months ended September 28, 2012, approximately 81% of our sales were derived from operations outside the U.S. We have significant manufacturing operations in European countries that are not part of the Eurozone. Sales revenues are more highly weighted toward the Euro and U.S. dollar. We also have significant contractual obligations, as discussed above, in U.S. dollars that are met with cash flows in other currencies as well as U.S. dollars. To better match revenue and expense as well as cash needs from contractual liabilities, we regularly enter into cross currency swaps and forward contracts.

We also face exchange rate risk from our investments in subsidiaries owned and operated in foreign countries. The €157.6 million term A-3 facility under the Deutsche Bank Credit Agreement (the “Term Loan A-3”), discussed above, provides a natural hedge to a portion of our European net asset position. The effect of a change in currency exchange rates on our net investment in international subsidiaries, net of the translation effect of the Company’s Term Loan A-3, is reflected in the Accumulated other comprehensive loss component of Equity. A 10% depreciation in major currencies, relative to the U.S. dollar as of September 28, 2012 (net of the translation effect of our Term Loan A-3) would result in a reduction in Equity of approximately $100 million.

We also face exchange risk from transactions with customers in countries outside the U.S. and from intercompany transactions between affiliates. Although we have a U.S dollar functional currency for reporting purposes, we have manufacturing sites throughout the world and a substantial portion of our costs are incurred and sales are generated in foreign currencies. Costs incurred and sales recorded by subsidiaries operating outside of the U.S. are translated into U.S. dollars using exchange rates effective during the respective period. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. dollar. In particular, the Company has more sales in European currencies than it has expenses in those currencies. Although a significant portion of this difference is hedged, when European currencies strengthen or weaken against the U.S. dollar, operating profits are increased or decreased, respectively.

We have generally accepted the exposure to exchange rate movements without using derivative financial instruments to manage this risk. Both positive and negative movements in currency exchange rates against the U.S. dollar will therefore continue to affect the reported amount of sales, profit, assets and liabilities in our Consolidated Financial Statements.

Commodity Price Risk

We are exposed to changes in the prices of raw materials used in our production processes. We periodically use commodity futures contracts to manage such exposure. As of September 28, 2012, we had no open commodity futures contracts.

See Note 14, “Financial Instruments and Fair Value Measurements” in our Notes to Condensed Consolidated Financial Statements included in this Form 10-Q for additional information regarding our derivative instruments.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of September 28, 2012. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective in providing reasonable assurance that the information required to be disclosed in the Company’s reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

The Company completed the Charter Acquisition on January 13, 2012. Management considers this transaction to be material to the Company’s Consolidated Financial Statements and believes that the internal controls and procedures of Charter have a material effect on the Company’s internal control over financial reporting. We are currently in the process of incorporating the internal controls and procedures of Charter into our internal controls over financial reporting and extending our compliance program under the Sarbanes-Oxley Act of 2002 to include Charter. The Company has elected to exclude Charter from the scope of its 2012 annual assessment of internal control over financial reporting as provided by the Act and the applicable SEC rules and regulations concerning business combinations.

Other than the Charter Acquisition noted above, there have been no changes in our internal control over financial reporting (as defined in Rule 13a-15(f)) identified in connection with the evaluation required by Rule 13a-15(d) of the Exchange Act that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1. Legal Proceedings

Discussion of legal proceedings is incorporated by reference to Note 15, “Commitments and Contingencies,” in the Notes to Condensed Consolidated Financial Statements included in Part I. Item 1. “Financial Statements” of this Form 10-Q.

Item 1A. Risk Factors

An investment in our common stock involves a high degree of risk. There have been no material changes to the risk factors included in Part I. Item 1A. “Risk Factors” in our 2011 Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

Item 6. Exhibits

Exhibit No.		Exhibit Description

3.01*		Amended and Restated Certificate of Incorporation of Colfax Corporation

3.02**		Colfax Corporation Amended and Restated Bylaws

3.03*		Certificate of Designations of Series A Perpetual Convertible Preferred Stock of Colfax Corporation

31.01		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.02		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.01		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.02		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS+		XBRL Instance Document

101.SCH+		XBRL Taxonomy Extension Schema Document

101.CAL+		XBRL Extension Calculation Linkbase Document

101.DEF+		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB+		XBRL Taxonomy Extension Label Linkbase Document

101.PRE+		XBRL Taxonomy Extension Presentation Linkbase Document

__________

* Incorporated by reference to Exhibits 3.01 and 3.02, respectively, to Colfax Corporation’s Form 8-K (File No. 001-34045) as filed with the SEC on January 30, 2012.

** Incorporated by reference to Exhibit 3.2 to Colfax Corporation’s Form 8-K (File No. 001-34045) as filed with the SEC on May 13, 2008.

+ In accordance with Rule 406T of Regulation S-T, the XBRL related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Registrant: Colfax Corporation

By:

/s/ STEVEN E. SIMMS	President and Chief Executive Officer	October 31, 2012
Steven E. Simms	(Principal Executive Officer)

/s/ C. SCOTT BRANNAN	Senior Vice President, Finance and	October 31, 2012
C. Scott Brannan	Chief Financial Officer
	(Principal Financial and Accounting Officer)